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Foreword 
This is the second report prepared for the Australian Health Policy Collaboration (AHPC) by 
Dr Sharon Willcox.  The first, Chronic diseases in Australia: the case for changing course, set 
out the cost of chronic diseases to individuals, the health system and the economy, and 
argued for national action on prevention. This second report, Chronic diseases in Australia: 
Blueprint for preventive action, looks at what can and should be done to improve 
population health and prevent illness. 
The AHPC explores health policy challenges, seeking to advance policy reform and to 
contribute to improved health outcomes.  The health program is focussed on chronic disease 
prevention, which has been identified by the Australian Institute of Health and Welfare 
(AIHW) as the biggest problem facing Australia’s health system.  
Chronic conditions such as diabetes, stroke and depression affect more than seven million 
Australians. The proportion of people with a chronic condition increases with age, and 
almost one in three Australians aged 45 or over have at least one chronic condition. The 
nation cannot afford to ignore an issue that affects so many of its people. 
This paper, written by Dr Sharon Willcox with the AHPC and a national expert advisory 
group, provides principles, strategic priorities and action areas for improved population 
health in Australia.  We are fortunate to have had input and advice from leaders in chronic 
disease prevention and management from the public, private and non-government sectors.  
Reducing chronic diseases through preventive interventions would provide significant 
benefits to individuals, communities, the health system, and the economy.  We believe that 
this paper will make a valuable contribution to a national action agenda, and to a 
measurable reduction in the incidence and impact of chronic diseases in Australia. 
Rosemary Calder 
Director 
Australian Health Policy Collaboration 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Executive summary 
This paper identifies strategic priorities for taking action to prevent chronic diseases.  It is 
the second report by the Australian Health Policy Collaboration on this issue.  The first 
report, Chronic diseases in Australia: the case for changing course, mapped out the social, 
economic and health costs of chronic diseases to the Australian community, as well as 
identifying the evidence on the effectiveness and cost-effectiveness of preventing chronic 
diseases. 
Chronic diseases in Australia: Blueprint for preventive action moves beyond the evidence to 
provide a framework for action that is summarised in the diagram on the next page.  The 
vision of this Blueprint is to reduce the impact and incidence of chronic diseases through 
preventive interventions. The desired outcomes, against which progress should be 
measured, comprise: 
• Healthy lives: improved health status for all populations. 
• Healthy children: a healthy future for our children. 
• Healthy communities: more liveable and socially connected communities. 
• Healthy economies: increased economic participation and productivity. 
To achieve this vision, action will be required on many fronts.  This recognises that chronic 
diseases have many shared risk factors and determinants, including health behaviours (such 
as smoking and physical inactivity), biomedical factors (such as high blood pressure and 
depression), and social and environmental determinants (such as early life conditions and 
socio-economic status).  Taking preventive action early includes tackling the underlying 
social determinants of poor health (primordial prevention) and implementing strategies to 
reduce specific risk factors for chronic diseases (primary prevention). Preventive actions to 
reduce the disease burden for high-risk populations, including people with risk factors or in 
the early stages of chronic diseases, are also vitally important.  
Seven core principles have been identified that shape the actions we propose to reduce the 
impact and incidence of chronic diseases: 
1. Systemic approach: focus on common risk factors and determinants, not individual 
diseases.  
2. Evidence-based action: act now using best available evidence and continue to build 
evidence. 
3. Tackling health inequity: work to improve and redress inequities in outcomes.  
4. National agenda with local action: build commitment and innovation with local 
action.  
5. A life course approach: intervene early and exploit prevention opportunities at all 
ages and across generations. 
6. Shared responsibility: encourage complementary actions by all groups. 
7. Responsible partnerships: avoid ceding policy influence to vested interests. 
This Blueprint identifies three strategic priorities, each of which includes specified actions.   
The first strategic priority is to drive healthy behaviours and healthy environments focussing 
on tackling the risk factors and social determinants that contribute to the burden of chronic 
diseases.   
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It involves setting measurable objectives and assessing preventive interventions in order to 
determine priority actions for implementation.   
The second strategic priority is to create accountability for action and monitoring progress. 
Areas for action include Australian implementation of the World Health Organization targets 
and indicators to prevent chronic diseases, as well as independent reporting.   
The third strategic priority is to generate community support and action on prevention. 
Many factors that are important in preventing chronic diseases require action by groups 
outside government.  Community support is also essential to achieving success, including the 
development of solutions that meet local circumstances and priorities.  
Responsibility for taking action on preventing chronic diseases must be shared.  Sustainable 
change requires partnerships and action by individuals and families, communities, the non-
government sector and governments.  
The Australian Health Policy Collaboration will work with partner organisations to implement 
the strategic priorities included in this Blueprint.  Work is already underway to auspice the 
development of an Australian set of indicators and targets that are consistent with the 
international target of a 25 per cent reduction in premature mortality from chronic diseases 
by 2025.  Following the release of this Blueprint, the Australian Health Policy Collaboration 
will continue to build a coalition of partner organisations committed to taking action on 
preventing chronic diseases.  
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1.Vision – why we need to take action on 
chronic diseases 
Australia has a strong track record of taking effective public health action to reduce harm 
and protect the health of our population.  The list of public health achievements over the 
past century is impressive, with just a few examples comprising : 1
• Turning HIV into a chronic condition, rather than a death sentence: Australia’s 
response to the HIV/AIDS epidemic involved effective community action, multi-
faceted public health intervention, and political commitment by governments to take 
bold action early in the epidemic.  Death rates fell from 6.4 deaths/100,000 men in 
1993 to 1 death/100,000 men by 2005, following the significant decline in HIV 
diagnoses.  Over the 25 years to 2010, public health programs to reduce HIV/AIDS 
cost $607 million, but resulted in a net benefit of $2.5 billion due to the reductions 
in mortality and morbidity.   2
• Significant reductions in drowning deaths among toddlers: Public health actions 
included the development of national standards on pool fencing, state-based 
legislation, local council inspections and water safety education campaigns. 
Subsequently, the number of drowning deaths among 0-4 year old children fell from 
an annual national average of 58 in the mid-1990s to 35 in 2003.  In Queensland, 
which has historically had the highest rates of child drowning, the installation of pool 
fencing saved the lives of more than 70 young children in the decade to 2002.  3
• Fewer deaths and injuries due to improvements in road traffic safety: Over five 
decades, action on road safety has included: compulsory seat belts, child restraints 
and helmets for cyclists and motorcyclists; reduced speed limits; the inclusion of 
safety design features in vehicles; restrictions on the use of alcohol and other drugs; 
random breath testing; and public education campaigns.  Road deaths fell from 8 
deaths/10,000 registered vehicles in 1970 to 1.4 deaths/10,000 registered vehicles in 
1999, while rates of serious injury have also declined significantly.  
• Reducing lead exposure in children: Following evidence about the adverse impact 
on intellectual development for children exposed to lead, public health programs in 
A vision, underpinned by evidence, of what 
can be achieved if we reduce chronic 
diseases is a critical prerequisite for 
effective action.  
A consistent set of messages reinforces the 
value of a system-wide approach to 
preventing chronic diseases that combines 
population-based and high-risk group 
preventive interventions. 
Selling the merits of success and dispelling 
the myths about why ‘it won’t work’ are 
essential tasks in prevention advocacy. 
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affected mining communities have included remediation of land and housing; 
population monitoring, case finding and case management; and public education and 
health promotion.  In Port Pirie, the rate of young children with blood lead levels 
above the National Health and Medical Research Council (NHMRC) targets declined 
from 98 per cent in 1984 to 55 per cent by 2001, with further improvements still 
required.  
While there have also been successes in tackling chronic diseases (most notably associated 
with tobacco control), public health action now needs to intensify to reduce the incidence 
and impact of all chronic diseases. This is central to our vision. 
 
The following sections revisit the compelling case for change. Section 1.1 outlines the scope 
and magnitude of chronic diseases in Australia, as well as the factors contributing to the 
growing burden of chronic diseases. Section 1.2 highlights the desired outcomes of achieving 
this vision, while Section 1.3 presents a typology of prevention and explains the 
complementary approaches to preventing chronic diseases.   
1.1 Chronic diseases – a growing burden with many interrelated 
causes  
Chronic diseases – referred to as non-communicable diseases (NCDs) by the World Health 
Organization (WHO) – comprise a range of conditions that are long-lasting and impact 
negatively on health status, including through the presence of disease symptoms, functional 
impairment, disability, reduction in healthy life expectancy and premature deaths.  
The scope of chronic diseases may be defined narrowly or more broadly, depending upon the 
basis of the classification.  Organisations may use different groupings of chronic diseases 
according to whether their focus is: preventability of shared risk factors; impact on 
morbidity and healthy functioning; capacity for improving service delivery and integrating 
care; or how they contribute to premature deaths.  For example, some common groupings of 
chronic diseases are: 
• World Health Organization: The WHO describes four main types of NCDs, 
comprising: cardiovascular diseases (CVDs) (such as heart attacks and stroke), 
cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease 
and asthma) and diabetes.  These four diseases account for 82 per cent of all deaths 
due to NCDs.   4
• Australian Governments: Under the 2005 National Chronic Disease Strategy , 5
Commonwealth and state and territory governments decided to focus on the five 
national health priority areas of asthma; cancer; diabetes; heart, stroke and 
vascular disease; and osteoarthritis, rheumatoid arthritis and osteoporosis.  This was 
linked to the development of national service improvement frameworks that 
identified opportunities for improvements in prevention and treatment of these 
chronic diseases.  Additional national health priority areas were identified after the 
development of the 2005 Strategy, including obesity (in 2008) and dementia (in 
2012).   
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VISION 
To reduce the incidence and impact of chronic 
diseases through preventive interventions
• Australian Institute of Health and Welfare: The AIHW lists 12 chronic conditions 
identified in the National Public Health Partnership’s report, Preventing chronic 
disease: a strategic framework.   It states that these conditions pose a significant 6
morbidity and mortality burden, incur significant health costs and are amenable to 
preventive measures.  The 12 chronic conditions are: ischaemic heart disease; 
stroke; lung cancer; colorectal cancer; depression; Type 2 diabetes; arthritis; 
osteoporosis; asthma; chronic obstructive pulmonary disease; chronic kidney 
disease; and oral disease.  
This Blueprint adopts a broad definition based on the shared risk factors and preventability 
of many chronic diseases. Table 1.1 outlines the scope of chronic diseases covered by this 
Blueprint, together with the common sets of health behaviours, biomedical factors, and 
social and environmental determinants that contribute to the development of these chronic 
diseases.  
Table 1.1 illustrates the value of a systemic approach to preventing chronic diseases. 
Each of the listed risk factors and determinants has an effect in contributing to two or more 
chronic diseases.  Accordingly, action on the underlying risk factors and determinants, 
rather than tackling individual chronic diseases, will generate the greatest improvement 
in outcomes.  
Data illustrating the impact and growing burden of chronic diseases in Australia includes:  
• Risk factors for chronic diseases are already present among young children and 
adolescents.  About one in four children are overweight or obese including very 
young children.  In 2011/12 some 16 per cent of children aged between five and 
seven years old were overweight and a further 8.7 per cent were already classified as 
obese.   The presence of obesity among such young children is particularly 7
concerning as it appears to play a critical role in triggering the development of other 
risk factors for chronic diseases.   One serious problem that has emerged is that Type 8
2 diabetes is now being diagnosed among children and adolescents, whereas it was 
previously an ‘adult’ disease.  The WHO has estimated that Type 2 diabetes accounts 
for almost one half (45 per cent) of all new cases of diabetes among children and 
adolescents.  9
• In 2012/13, about 1.8 million hospital admissions were related to CVD, diabetes and 
chronic kidney disease (CKD).  This is equivalent to one in every five hospital 
admissions annually associated with these three chronic diseases.  While 
hospitalisation rates are declining for CVD, they are increasing for diabetes and CKD. 
People frequently have two or more of these chronic diseases.  Excluding dialysis, 
there were about 390,000 hospital admissions where patients had a combination of 
CVD, diabetes and CKD.  In 72 per cent of these admissions, patients had two of 
these chronic diseases, while in 28 per cent of these admissions patients had all 
three.   10
• Due to their early onset and prevalence among young people, mental health 
conditions have been called the ‘chronic diseases of the young’.   About 500,000 11
children and adolescents (14 per cent of people aged 4 to 17 years) experience a 
mental health problem.   As mental health conditions often start early in life, they 12
account for one-quarter of years of life lived with a disability.   Mental health 13
conditions rank third after CVD and cancer as the most significant contributor to the 
number of healthy life years lost due to living with a disability.  
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Table 1.1: Chronic diseases have many shared risk factors and determinants  
√ = Established link   + = Association/comorbidity  ? = Possible link 
Notes/Sources: 
1. The categories of risk factors and determinants are based on the AIHW’s Framework for the Determinants of 
Health in Australia’s Health 2014 (Figure 1.1).  14
2. The attribution of links between most of the chronic diseases, risk factors and determinants is drawn from 
the Victorian Public Health and Wellbeing Plan 2011-2015 (Figure 4).    15
3. The assignment of risk factors and determinants for chronic kidney disease is based on the AIHW’s 2009 
report, Prevention of cardiovascular disease, diabetes and chronic kidney disease: targeting risk factors (Table 
2.1).   16
4. The evidence on risk factors and preventability of dementia is still developing, noting that there are many 
different forms of dementia. ,    17 18
Categori
es1 
Risk 
factors and 
determinan
ts2
Cancers Cardiovascul
ar diseases 
(incl. heart 
attack & 
stroke)
Chronic 
kidney 
disease3
Dementia
4
Type 2 
Diabetes
Mental 
health 
condition
s
Musculos
keletal 
condition
s (incl. 
arthritis)
Respirato
ry 
diseases 
(incl. 
asthma)
Health 
behaviou
rs
Tobacco 
use
√ √ √ ? √ + √ √
Alcohol 
misuse
√ √ √ √ + √
Nutrition √ √ √ ? √ + √ ?
Physical 
activity
√ √ √ ? √ √ √
Biomedic
al factors
Hypertensio
n
√ √ ? + +
High 
cholesterol
√ ? +
Excess 
weight
√ √ √ ? √ + √
Depression + √ ? ? + √ +
Social 
and 
environm
ental 
determin
ants
Chronic 
stress
? ? ? √ ?
Social 
support
√ ? √
Early life 
(including 
low birth 
weight)
? √ √ √ √ √
Low socio-
economic 
status 
√ √ + ? √ √ √
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• At the other end of the age spectrum, dementia was the fourth leading cause of 
the overall burden of disease in Australia in 2011.  This significant burden of 
disease flows from the relatively high prevalence of dementia in older 
populations.  It has been estimated that in 2011, 9 per cent of all Australians aged 
65 and over had dementia, with this increasing to 30 per cent of people aged 85 
and over.  About three-quarters of the burden of disease caused by dementia is 
due to its disabling nature, while one-quarter is associated with premature 
mortality.   19
• The burden of chronic disease is unevenly distributed, with higher rates of 
chronic diseases and risk factors among disadvantaged populations.  Indigenous 
Australians have a significantly higher age-standardised mortality rate for all 
cancers combined (221 per 100,000 people) than non-Indigenous Australians (172 
per 100,000 people).   People living in rural and remote areas have higher levels 20
of some risk factors for chronic diseases arising from comparative health and 
socio-economic disadvantage. ,   The burden of chronic diseases (comprising 21 22
reduced life expectancy and years lived with a disability) is 32 per cent higher for 
the most disadvantaged Australians (people in the lowest 20 per cent of socio-
economic status) than for the most advantaged Australians (people in the highest 
20 per cent of socio-economic status).   Mental health and CVD are the largest 23
contributors to the higher burden of disease among disadvantaged populations.  
1.2 The case for change – outcomes of tackling chronic diseases  
There are major gains to be realised if the incidence and impact of chronic diseases can 
be reduced.  These gains extend beyond the impact on the health of individuals to our 
children’s future, the wellbeing of the communities in which we live, and the economic 
prosperity of our society.  
The gains that could be achieved through reducing the incidence and impact of chronic 
diseases are illustrated by examples in four outcome domains: 
Potential gains include: 
• If Australians met the national physical activity guidelines, we could reduce 
coronary heart disease deaths by 33 per cent, colon cancer deaths by 25 per cent, 
diabetes cases by 25 per cent, stroke risk by 15 per cent and breast cancer risk by 
12 per cent.  24
• If the Australian Government introduced mandatory salt limits for 
manufacturers of just three food groups (bread, margarine and cereal products), 
this could result in 110,000 fewer years lived with a disability, as well as 
generating savings of $1.43 billion.   This would complement and achieve a 20-25
fold increase in the population health benefits of the National Heart Foundation’s 
existing Tick program.    26
Healthy 
lives 
√ Improved health status for all Australians
  | P a g e  ix
A u s t r a l i a n  H e a l t h  P o l i c y  C o l l a b o r a t i o n  2 0 1 5
Potential gains include:  
• If unhealthy food advertising was banned on TV during children’s peak viewing 
times, this would result in 37,000 disability-adjusted life years (DALYs) saved.  27
Similar restrictions in the UK on advertising high fat, sugar and salt foods during 
children’s TV programs resulted in a 37 per cent reduction in unhealthy food 
advertisements seen by children.   The implementation of such a ban in Australia 28
would be highly cost-effective, generating net savings of about $300 million.   29
• If psychological therapy was made available to high-risk children and 
adolescents (assessed as high-risk following screening), this would result in 
about 5,600 DALYs saved.  Most of the improved health outcomes for these 
children and adolescents would be due to the reduction in depressive episodes 
(94 per cent), but suicides would also be prevented (6 per cent of the DALYs 
averted).   Depression and anxiety are very common among young people: one in 30
16 young Australians (16-24 years) is currently experiencing depression and one in 
six is currently experiencing an anxiety condition.   In 2012, there were 324 31
deaths by suicide among young Australians aged 15-24 years, higher than the 
number of young Australians (198) dying in car accidents.  32
Potential gains include: 
• If effective action was taken to reduce the harmful consumption of alcohol, 
this could generate net savings for social costs of $15 billion (2004/05 costs). 
Some of the significant (non-health sector) social costs include: $1.6 billion in the 
costs of crime (such as policing, criminal courts and prisons) that is directly 
attributable to alcohol abuse; $2.2 billion in the costs of road accidents; and $3.6 
billion in workplace productivity losses.   Our communities could be much safer. 33
According to the Australasian Centre for Policing Research, alcohol is involved in 
62 per cent of all police attendances, 40 per cent of domestic violence incidents, 
73 per cent of assaults and 77 per cent of street offences.  34
• If a small shift to active travel (walking and cycling) and public transport was 
achieved, greenhouse gas emissions could be reduced by up to two-thirds for peak 
travel and by about 95 per cent for off-peak travel.   The joint potential to 35
improve our environment and our waistlines is significant.  Nearly 40 per cent of 
Australians commute less than 10 kilometres to work or study, but only 1.6 per 
cent cycle and only 4.2 per cent walk to work.   Increasing active travel and 36
public transport can also improve the quality of life in Australian cities through 
reducing traffic congestion.  The Bureau of Transport and Regional Economics has 
estimated that the annual avoidable cost of traffic congestion in Australian cities 
will rise from almost $10 billion in 2005 to over $20 billion by 2020.   37
Healthy 
children
√ A healthy future for our children
Healthy 
communiti
es
√ More liveable and socially connected 
communities
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Potential gains include: 
• If chronic diseases were eliminated, the Business Council of Australia has 
estimated that this could increase the workforce by 10 per cent, boosting the 
productivity of the Australian economy by 10 per cent.   The loss to the Australian 38
labour force from people suffering from chronic diseases is estimated to be 
537,000 full-time person years and 47,000 part-time person years.  
• If the prevalence of six risk factors for chronic disease could be reduced to 
realistically achievable levels, this could boost the economy by $2.3 billion.  (The 
six risk factors are: smoking, high-risk alcohol use, physical inactivity, intimate 
partner violence, obesity and inadequate diets).  This comprises savings of $1.5 
billion through reducing health sector costs and $0.8 billion through reducing 
workforce productivity losses and costs to households.   39
These benefits – healthy lives, healthy children, healthy communities and healthy 
economies – are substantial.  They are also achievable – if we have engagement and 
political commitment to taking effective preventive action on chronic diseases.  In case 
we doubt the potential for systemic public health action to improve our health and safety 
significantly, Box 1.1 provides a reminder of the immense improvements to road safety 
achieved over the past five decades and the impact had they not occurred.  
Healthy 
economies
√ Increased economic participation and 
productivity
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Box 1.1: The future re-imagined for road safety without public health 
interventions 
In the words of John Lennon, Imagine: 
It is 1965. 
For the first time, the number of annual road deaths in Australia exceeds 3,000 people. 
There has been a 50 per cent increase over the past decade associated with rising rates 
of car ownership. 
In the United States (US) Ralph Nader does not publish his groundbreaking book, Unsafe 
at any speed.  The concept of designing in safety does not come into existence and the 
car industry of the future does not invest in head restraints, airbags and crumple zones.  
It is 1969. 
The Royal Australasian College of Surgeons does not establish a Road Trauma Committee. 
Road deaths and injuries are viewed as inevitable ‘accidents’, rather than as a 
preventable public health problem.  Orthopaedic surgeons have instead pioneered new 
approaches to treating the victims of road accidents.  There is a severe shortage of 
orthopaedic surgeons.   
It is 1973. 
Australian governments have unofficially adopted the ‘Live free or die’ philosophy 
(copying the state motto of New Hampshire).  Brief public debate on legislating for 
compulsory wearing of seat belts and motor cycle helmets fizzled before it started.  The 
new Action on Road Safety Association has fewer members than the Anti-Football 
League.  
It is 1987. 
The Victorian Government does not establish the Transport Accident Commission. 
Innovative road safety educational campaigns (If you drink then drive, you’re a bloody 
idiot; Don’t fool yourself, speed kills; and Knock off five) are not created.  Ten years 
hence, Tourism Australia’s campaign (Where the bloody hell are you?) receives 
international advertising awards for its edgy language, but brickbats from grammar 
pedants.   
It is 2001. 
Reduced speed limits for roads near schools are not introduced.  Governments argue 
that parents and children need to take responsibility for their behaviours and not put 
themselves in danger.  The term ‘nanny state’ is unknown and is not used by tobacco 
companies in 2011 to challenge advertising bans.  People continue to think fondly of 
nannies and remember watching Mary Poppins at the movies.   
It is 2014. 
The number of road deaths and injuries has kept pace with population growth and car 
ownership.  Every public and private hospital now has its own road trauma ward and 
most communities have rehabilitation hospitals.  Shares in private sector companies that 
provide wheelchairs, aids and appliances represent blue chip investments.  
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1.3 Defining prevention and approaches to tackle chronic 
diseases 
Many factors contribute to the development of chronic diseases.  Table 1.1 identified 
some of the health behaviours, biomedical factors, and social and environmental 
determinants that are linked to the most common chronic diseases.  This complex, 
multi-causal aetiology of chronic diseases means that prevention must also involve 
action on many fronts: 
• at different stages along the disease causation chain: in well populations; in 
populations with risk factors and other determinants for chronic diseases; in 
people in the early stages of chronic diseases; and in people with long-term 
chronic diseases; 
• at different stages of the life course: before birth; in early childhood; in 
adolescence; in early adulthood; in middle age; in older populations; and across 
generations; 
• in different settings: in GP clinics; in acute and specialised health services; in 
schools and other educational institutions; in workplaces; in community groups; 
and in sporting clubs; and 
• by different individuals and organisations: parents and families; community 
associations; educational institutions; local governments; health services; private 
health insurers; employers and business associations; sporting associations; non-
government organisations; the media and advertising industry; and 
Commonwealth and state/territory governments.  
‘Prevention’ means different things to different people.  The National Public Health 
Partnership developed a valuable prevention typology  that defines the levels of 40
prevention according to a ‘stages of disease’ continuum, as follows: 
• Primordial prevention: this involves preventing the emergence of predisposing 
social and environmental conditions that can lead to causation of disease.   
o An example of primordial prevention is interventions to tackle early 
childhood disadvantage to overcome the ‘poorer platform of health’ 
experienced by children in disadvantaged families.   This could include 41
financial support for pre-school provision to children experiencing 
significant disadvantage and parenting programs for disadvantaged 
families.  42
• Primary prevention: this includes limiting the incidence (development of new 
cases) of chronic diseases through eliminating or reducing specific risk factors and 
other determinants, while promoting factors that are protective of health.   
o Examples of primary prevention include: legislation to make seatbelts 
compulsory; urban design that provides safe environments for walking, 
cycling and other physical activities to encourage active lifestyles; and 
plain packaging of tobacco to decrease the number of children who take 
up smoking.   
• Secondary prevention: this involves reducing the progression of chronic diseases 
through early detection (usually by screening at an asymptomatic stage) and early 
intervention.   
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o An example of secondary prevention is dietary management and the 
promotion of physical activity for people at risk of diabetes to reduce or 
delay the onset of that disease.  
• Tertiary prevention: this involves improving function and minimising the impact 
of established disease.  It also includes preventing or delaying complications 
through effective management and rehabilitation.   
o An example of tertiary prevention is cardiac rehabilitation for people who 
have established CVD and have suffered a heart attack.   
The categories in this prevention typology are not absolute and there is inevitably 
blurring as to how specific preventive interventions are classified.  There is also blurring 
between whether interventions are described as ‘preventive’ or ‘therapeutic’.  For 
example, many people would classify most of the interventions in the tertiary prevention 
category as treatments, not prevention.  
Prevention can be targetted at individuals (whether healthy, at risk, symptomatic or 
with established chronic diseases), at communities (including geographically-based 
communities or specific population groups such as Indigenous people or parents with 
young children) and at the total population (see Figure 1.1).  Secondary and tertiary 
prevention activities are usually targetted at individuals (mainly at high-risk individuals 
who have multiple risk factors and/or established chronic diseases), while primordial and 
primary prevention activities can be targetted to the total population or specific 
communities.   
Figure 1.1: Action to prevent chronic diseases can be targetted at individuals, 
communities and whole populations 
  
Individuals   
(eg. dietary advice for people 
with high blood pressure) 
Communities   
(eg. exercise programs for 
targeted groups)
Total population 
 (eg. national salt reduction 
targets)
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The focus of this Blueprint is encouraging preventive interventions that reduce the 
incidence and impact of chronic diseases.   
In relation to the prevention typology and approaches outlined in the previous pages, it is 
clearly desirable first to prevent the development of chronic diseases (the aim of 
reducing incidence).  This means that there should be a high priority given to 
primordial and primary prevention strategies that tackle the underlying social 
determinants of poor health, as well as specific risk factors (including behavioural and 
biomedical risk factors) for chronic diseases.  This is consistent with a systemic approach 
to prevention that focusses on the risk factors and determinants that are common to 
many chronic diseases.  Intervening early through primordial and primary prevention can 
help reduce the burden of disease and health system costs associated with the 
subsequent treatment of people with chronic diseases. 
However, it is also recognised that these ‘upstream’ forms of prevention need to be 
complemented with ‘downstream’ preventive interventions.  This includes reducing the 
disease burden for high-risk populations including people with risk factors and/or in 
the early stages of chronic diseases (the aim of reducing the impact of chronic 
diseases).  Secondary prevention includes, for example: 
• Targetting high-risk populations such as people with risk factors for Type 2 
diabetes to prevent the onset of disease.  
• Screening and the provision of early intervention services for adolescents who may 
be at risk of mental health conditions such as depression and anxiety. 
• Reducing risk factors in people with chronic diseases.  For example, the Australian 
guidelines on CVD emphasise the value of managing absolute risk through a 
comprehensive approach to tackle multiple risk factors (such as smoking, 
hypertension, insufficient physical activity, high cholesterol).   43
These two approaches  are sometimes distinguished as: 44
• ‘population-based’ prevention – taking preventive action to influence outcomes in 
the ‘total’ population, usually through primordial and primary prevention 
strategies; or 
• ‘high-risk group’ prevention – taking preventive action to influence outcomes in 
targetted sub-populations (groups of high-risk individuals), usually through 
secondary prevention strategies.  
Both approaches are intended ultimately to influence outcomes for individuals, 
notwithstanding that they are directed at either the total population or high-risk sub-
populations.  
This Blueprint is intended to promote action through both population-based and high-
risk group prevention.  It does not cover treatment of patients with established chronic 
diseases.  
One aspect of building support for prevention is setting the facts straight.  Section 1.4 is 
about myth-busting – providing the evidence and arguments to counter some of the 
common claims made by critics of prevention.  
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1.4 Dispelling the myths – responding to the critics of prevention 
Three of the most common criticisms about prevention are assessed and debunked as 
myths.  
In refuting this myth, some of the evidence and arguments that have and can be used by 
public health advocates include: 
Interventions should always be based on the best available evidence of effectiveness 
including cost-effectiveness.  Making claims that ‘prevention doesn’t work’ is as flawed 
as arguing that ‘all treatment works’.  In both cases, there should be independent 
assessment of both the effectiveness of an intervention (does it work?) and its cost-
effectiveness (what are the comparative costs and outcomes of an intervention?).  There 
should also be processes for ongoing evaluation and review to allow informed decisions 
about investment or disinvestment. 
Often, it seems as if we hold preventive interventions to a higher standard than 
treatment interventions.  This may partly be due to the ‘rule of rescue’ – that it may be 
difficult to resist trialling treatments for very ill individuals even if there is no proven 
benefit of their effectiveness.  In contrast, the beneficiaries of successful preventive 
interventions (such as people who do not develop lung cancer or do not have road 
accidents) are not usually readily identifiable.  
Another reason for the differential assessment of prevention and treatment interventions 
is that there is no systematic approach to evaluating preventive interventions because of 
the absence of a dedicated funding stream for prevention.  The cost-effectiveness of new 
medical interventions and pharmaceuticals are assessed for potential inclusion on the 
Pharmaceutical Benefits Scheme (PBS) and Medical Benefits Scheme (MBS) respectively. 
It has been proposed that Australia needs a similar approach to assess the evidence on 
the effectiveness and cost-effectiveness of particular preventive interventions – a 
Preventative Priorities Advisory Committee (similar to the Medical Benefits and 
Pharmaceutical Benefits Advisory Committees).    45
The legislation authorising the establishment of the Australian National Preventive Health 
Agency (ANPHA) identified the organisation’s first objective as being ‘to effectively 
monitor, evaluate and build evidence in relation to preventive health strategies’. Given 
the recent disbanding of ANPHA, it is critical to continue to build, and to communicate, 
the evidence-base on the effectiveness of population-based interventions in preventing 
chronic diseases.  
Population-based prevention doesn’t work and is a 
waste of money  
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There is robust evidence that some preventive interventions are relatively 
affordable and score well on cost-effectiveness in that they generate net savings. 
Major Australian and international studies have identified many preventive interventions 
that both work (that is, they are ‘effective’) and are cost-effective.  In addition to 
effectiveness and cost-effectiveness, another important criterion is the affordability of 
preventive interventions.  Policy-makers and funders require information on the: 
• up-front costs (or affordability) of implementing preventive interventions, 
including who bears these costs (for example, governments, industry, consumers); 
and 
• return on investment relating to whether these interventions ultimately have a 
net cost or net savings, again including consideration of who bears/gains the 
costs/savings of these interventions.  
Some interventions may be highly cost-effective, but may have high up-front costs and 
may not be able to be accommodated within existing budgetary constraints.  Other 
interventions may be relatively affordable (such as government regulation and taxes on 
unhealthy products) and also perform well on cost-effectiveness.  
One of the most important Australian studies is the Assessing Cost Effectiveness (ACE)-
Prevention study, which evaluated the effectiveness of 150 preventive health 
interventions.  The assessed interventions included both population-based and high-risk 
group preventive interventions covering areas such as mental health, diabetes, tobacco 
use, alcohol use, nutrition, body weight, physical activity, blood pressure, blood 
cholesterol and bone mineral density.  
The ACE-Prevention study identified interventions that would reduce risk factors, lessen 
the burden of chronic diseases and result in net savings.  Table 1.2 provides a summary of 
the benefits of five population-based preventive interventions related to the use of 
taxation or regulation of tobacco, alcohol and unhealthy foods.  These interventions 
result in healthier lives (fewer years living with a disability) and are highly cost-effective. 
For example, a 10 per cent tax on unhealthy foods would generate almost $3.5 billion in 
cost savings and produce a health gain of 170,000 DALYs prevented.  Table 1.2 also 
includes two preventive interventions targetted at high-risk populations.  These 
interventions would result in healthier lives for people at risk of CVD.  There are 
significant cost savings associated with the polypill, or a combination of blood-pressure 
lowering drugs, largely due to the inefficient nature of current practice.  
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Table 1.2: Impact of implementing the most cost-effective preventive 
interventions for chronic diseases 
Note: DALY is disability adjusted life year.  
Source: Based on Table 0.1 in: Vos et al. 2010, Assessing cost-effectiveness in prevention (ACE-
Prevention) Final Report, University of Queensland, Brisbane and Deakin University, Melbourne. 
The most common argument used to challenge proposals for population-based 
interventions is that most chronic diseases could be prevented if people watched what 
they ate or exercised more.  One example of this argument is as follows: 
Lifestyle modification and sustaining changes to unhealthy but often pleasurable 
behaviours is principally an individual responsibility.  Success in avoiding lifestyle 
disease ultimately depends on personal qualities – will, self-discipline, and 
impulse control – that public health policies struggle to instil in people who do 
not already possess them.  46
Proponents of personal responsibility sometimes go further and suggest that people with 
‘lifestyle diseases’ should not have their health costs met by Medicare.  
In refuting this myth, some of the evidence and arguments that have and can be used by 
public health advocates include: 
Intervention DALYs 
prevented
Intervention 
costs (A$ 
billion)
Cost offsets 
(A$ billion)
Net costs 
(A$ billion)
Cost/DALY
Tobacco tax 30% 
increase 
270,000 0.02 -0.7 -0.68 Savings
Alcohol tax 30% 
increase
100,000 0.02 -0.5 -0.48 Savings
Alcohol volumetric tax 
10% above current 
excise on spirits
110,000 0.02 -0.7 -0.68 Savings
Unhealthy foods tax 
10%
170,000 0.02 -3.5 -3.48 Savings
Mandatory salt limits 
on processed food
110,000 0.07 -1.5 -1.43 Savings
Three blood-pressure-
lowering drugs to 
replace current 
practice of preventive 
drug treatments
20,000 -1.9 -0.3 -2.2 Savings
Polypill to replace 
current practice
60,000 -7.0 -0.8 -7.8 Savings
Preventing chronic diseases is all about personal 
responsibility and individual choices 
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The obesogenic environment promotes unhealthy choices: There have been major 
shifts in the availability of unhealthy food and drinks, with growing portion sizes and 
rising levels of sugar and salt.  Such factors effectively ‘hijack biological and 
psychological regulatory systems that govern eating and weight’  creating an 47
environment where it is extremely difficult to make responsible eating choices.  There is 
clear evidence of the critical importance of the changing environment relative to 
individual choices as a major driver of obesity.  For example, research has consistently 
identified that people moving from less to more obese countries gain weight and those 
moving to less obese countries lose weight, with a recent systematic review examining 
the complex factors that contribute to this phenomenon of ‘acculturation’.    48
We need to make ‘healthy choices, easy choices’: The ‘it’s all down to personal 
responsibility’ mantra assumes well-functioning markets: that everyone has perfect 
information about the risks and benefits of particular behaviours; that they act in 
rational self-interest; and that individual decisions are not influenced by external factors, 
including societal pressures and environmental conditions.  These assumptions are not 
correct. Behaviours, such as healthy eating, are influenced by the accessibility and 
affordability of healthy food.  Teenagers eat fewer servings of fruits and vegetables and 
are more likely to be overweight or obese if their schools are within close proximity to 
fast-food outlets.   49
The concept of ‘choice architecture’ is based on reconciling and recognising the 
complementary roles of individual and collective responsibility.  Examples of choice 
architecture that can ‘nudge’ people towards healthier behaviours include the redesign 
of menus in school cafeterias or using information to correct misperceptions about levels 
of binge drinking to create new social norms.  50
Some unhealthy consumption involves addictive behaviours which are much more 
complex to change than simply advocating ‘just say no’: Blaming individuals for 
unhealthy behaviours such as excessive alcohol consumption, tobacco smoking and binge 
eating habits fails to recognise the complexity of achieving sustained behaviour changes. 
The challenges in responding to addictive behaviours and compulsions are illustrated 
through use of electronic and social media.  While we might all recognise the increased 
productivity achievable through only checking our emails at set times each day, very few 
people can resist the pressure to be ‘in the loop’.  Behavioural economics has identified 
the many ways in which human behaviour is ‘predictably irrational’, rather than 
conforming to expectations of healthy behaviours.   51
Many people, including children, cannot make informed healthy choices: Children are 
no match for industries that manufacture and promote unhealthy products in ways 
designed to create unhealthy social norms and behaviours.  To suggest that this is in any 
way a level playing field is to stretch the paradigm of personal responsibility beyond the 
boundaries of credulity.  Yet, unhealthy industries consistently deny that they are 
marketing to children or claim that parents should take responsibility for children’s diets 
and physical activity levels.  Even adults struggle to make healthy choices in the context 
of our food-rich, hyper-consumption environment where there is an overwhelming 
amount of ‘choice’ (as exemplified by the dozens of brands for each product line in 
supermarkets), but very limited factual information to guide those choices.  While the 
Australian Dietary Guidelines exhort people ‘to choose foods and drinks more wisely’,  52
the inadequacy of current food labelling in Australia seriously undermines the ability for 
either children or adults to make healthy choices. 
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The ability to make healthy choices is also influenced by social and environmental factors 
including the level of education, income and social supports.  Social and economic 
disadvantage may severely limit the capacity of individuals to make informed choices 
about behaviours that are risk factors for chronic diseases.  For example, low levels of 
‘health literacy’ among people with limited education can influence the ability to make 
healthy choices.  Diminished social capacity means that there is not a level playing field 
when it comes to taking personal responsibility for healthy behaviours.  
The Australian Bureau of Statistics (ABS) defines health literacy as ‘the knowledge and 
skills required to understand and use information relating to health issues such as drugs 
and alcohol, disease prevention and treatment, safety and accident prevention, first aid, 
emergencies and staying healthy’.   In its 2006 survey, the ABS found that 60 per cent of 53
adults lack basic proficiency in health literacy.  This existing problem of low literacy is 
compounded when information to guide health choices is not readily understandable.  A 
recent Australian study assessed about 250 web pages with information on twelve 
common health conditions to evaluate their readability compared with the average 
reading level of Australians.   The twelve conditions were: anxiety, arthritis, asthma, 54
back pain, bowel cancer, breast cancer, depression, diabetes, dementia, heart disease, 
obesity and prostate cancer.  Using the aptly named SMOG (Simple Measure of 
Goobledygook) formula, only 0.4 per cent of web pages were written at or below grade 8, 
which was the benchmark recommended by SA Health as a guide.  The readability of 
health information web pages varied by health conditions and by sector: information on 
dementia was unfortunately the most difficult to read, while government health 
information web pages were significantly harder to read than not-for-profit web pages.  
The spectre of the ‘nanny state’ is frequently evoked when governments are 
contemplating regulations that are designed to keep people healthy.  In response to the 
Australian Government’s proposal to introduce plain packaging for cigarettes, the 
tobacco industry ran a short-lived media campaign in 2011, with a stern woman (dressed 
in quasi-prison officer garb) warning smokers of the dangerous precedents that would 
flow from this legislation.  Such critics often characterise government action on public 
health as ‘paternalistic’ and infringing on personal liberties.   
In refuting this myth, some of the evidence and arguments that have and can be used by 
public health advocates include: 
We should prioritise health outcomes, not commercial interests: It is noteworthy that 
the proponents of the nanny state argument are most often those whose commercial 
interests are threatened, rather than the intended beneficiaries of government actions. 
The organised opposition to plain packaging did not come from consumers wary of 
government intervention, but was driven by the tobacco industry, some retailers and 
newly-established lobby groups.  Astroturfing – the practice of funding and orchestrating 
apparently independent organisations to simulate grassroots opposition to public health 
policies – has been used by tobacco and food and soft drink manufacturers in Australia 
and internationally. , ,   55 56 57
The public doesn’t want a ‘nanny state’ where 
governments tell them what they can and can’t do 
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Governments should act to create a level playing field to counter industry 
domination and enable informed consumer choice: In criticising the nanny state, 
industry often claims that government regulation is ‘interference’ in the free market and 
that this reduces personal freedoms.  However this can be reframed to recognise that 
much government action is about allowing individuals to make informed choices, free 
from the ‘domination’ of industry advertising and other strategies.   It is actually 58
industry that plays the role of the ‘nanny’ when it markets junk food to children, when it 
distorts the facts about the harm caused by alcohol or when it fails to ensure that food 
products are subject to an effective food-labelling scheme.  Action by governments 
provides a counter-balance to this industry domination.  It creates a level playing field so 
that consumers can make informed choices.  
A pure market ‘buyer-beware’ philosophy is inadequate when health risks are 
significant: There are many examples where governments have responded to evidence of 
public harm to enact balanced regulation, or take other actions, to keep people safe. 
This includes: prohibiting the sale of flammable nightwear for children; setting standards 
and undertaking inspections related to food safety; making it mandatory to use safety 
glass in showers; banning solariums; and the introduction of age limits for the purchase of 
alcohol and tobacco products.  In these and many other examples, there is legitimate 
community expectation that governments will act to protect public health, rather than 
putting the onus solely on individuals to avoid and/or be fully informed about the risks of 
dangerous products.  
There is popular support for government intervention to protect public health: 
Often, the public is ahead of governments in supporting regulation or other approaches to 
protect public health.  Some examples are: 
• In 2013, the National Drug Strategy household survey found that there was 
majority support for a wide array of interventions to tackle alcohol, including: 
stricter enforcement of laws against supplying minors (84 per cent); limiting TV 
advertising until after 9.30pm (73 per cent); requiring information on national 
drinking guidelines on all alcohol containers (65 per cent); serving only low-
alcohol drinks at sporting events (56 per cent); and banning alcohol sponsorship of 
sporting events (54 per cent).  While most people don’t support increasing the 
price of alcohol (28 per cent), there is substantial support for increasing the tax 
on alcohol to pay for health, education and the cost of treating alcohol-related 
programs (44 per cent).  59
• Australians have strong concerns about the health risks of childhood obesity and 
support actions to reduce consumption of junk food among children. In 2012, a 
national survey found that most people support a ban on advertising junk food 
during children’s programming (77 per cent).   Other approaches to discourage 60
consumption of junk food by children are also well supported.  Most Australians 
(77 per cent) support making the Health Star rating mandatory on all packaged 
foods, while half (50 per cent) support a tax on junk food/sugary drinks.   61
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2.Strategic priorities – turning 
knowledge   into action 
Having and communicating the evidence-base on the preventability of chronic diseases is 
not sufficient to ensure action.  It took many decades from the publication in the 1950s 
and 1960s of scientific studies and the US Surgeon-General’s reports on the dangers of 
tobacco smoking before governments took decisive regulatory and other action to reduce 
smoking rates. ,   62 63
For preventive action to happen, the knowledge base needs to be complemented by 
political commitment which, in turn, is shaped by community attitudes.   The 64
knowledge base also needs to be translated into a set of actionable strategies, with 
accountability through public reporting for delivery of such strategies and measurable 
improvements in the outcomes sought.   
Section 2.1 outlines a set of core principles that are central to the Blueprint action 
agenda and provide a common platform for interventions to prevent chronic diseases. 
Sections 2.2 to 2.4 present specific actions that will be promoted and supported through 
this Blueprint. These are grouped under three strategic priority areas: 
1. Driving healthy behaviours and healthy environments; 
2. Creating accountability for action and monitoring progress; and 
3. Generating community support for action on prevention. 
Finally, Section 2.5 outlines the need for a partnership approach where all groups have a 
role in taking action to prevent chronic diseases.  
2.1 Core principles – a common framework for action on chronic 
diseases 
Seven core principles have been identified to shape actions to reduce the impact and 
incidence of chronic diseases. These are detailed on the following pages. 
Translating public health knowledge into 
action requires community and political 
commitment. 
As the old joke goes, the light bulb has 
to  
want to change! 
Creating the climate and commitment 
for change is at the core of this 
Blueprint and is outlined in this section. 
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The rationale for a systemic approach to chronic diseases was clearly illustrated in Table 
1.1.  Chronic diseases share many common risk factors and determinants.  This extends 
beyond the more commonly understood ‘health behaviours’ (the SNAP quartet of 
smoking, nutrition, alcohol and physical activity) to a range of biomedical factors and 
social and environmental determinants.  Taking joint action across multiple chronic 
diseases leverages the shared risk factors and determinants for many of these diseases.   
The Australian Health Policy Collaboration’s Issues Paper - Chronic diseases in Australia: 
the case for changing course  - identified the wealth of information available on cost-65
effective interventions to prevent chronic diseases.  Further sources of evidence on cost-
effective interventions are also provided later in Section 2.2 of this Blueprint.  For now, 
the key messages are that: 
• We have good evidence on preventive interventions that are cost-effective. 
• Drawing upon this evidence, we should use existing funding more constructively by 
ensuring that investment is directed at cost-effective preventive interventions. 
The corollary is that we should not implement interventions that are not cost-
effective.  
• We should continue to collect and synthesise the evidence on preventive 
interventions.  
The evidence on the effectiveness of specific prevention interventions needs to be 
communicated and translated for policy-makers, public and private funders and other 
organisations that may have a role in implementing these interventions (such as local 
councils and workplaces).  A range of Australian organisations already undertake this role, 
including the Sax Institute, the Centre of Excellence in Intervention and Prevention 
Science, and the Cochrane Public Health Review Group at the McCaughey VicHealth 
Centre for Community Wellbeing.  Despite the existence of these organisations and the 
landmark Australian ACE-Prevention study, there is still limited awareness about the 
evidence-base for preventive interventions.   
The other important element of this core principle is that instead of deferring action 
until definitive analyses are available, prevention advocates need to recommend action 
using the best available evidence.  Critics are often quick to claim that ‘further studies 
are required’.  For example, in their opposition to the introduction of plain packaging in 
Australia, the tobacco industry argued sequentially that ‘it’s never been done before’ and 
therefore ‘there’s no evidence it will work’.   Rather than be dissuaded by these tactics, 66
prevention advocates worked with the Australian Government to assemble and review the 
evidence, including commissioning a series of studies to specifically test the design 
elements of the proposed approach to plain packaging.  
Systemic approach √ Focus on common risk factors and 
determinants not individual diseases
Evidence-based 
action
√ Act now using best available evidence, 
continue to build evidence
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The importance of social determinants in influencing the development of chronic 
diseases, together with the well-known gradient of disadvantage for many health 
behaviours such as smoking and drinking, makes it vital that preventive interventions also 
target disadvantaged communities and populations.   
It is not sufficient to simply achieve risk factor reductions at a whole-of-population level. 
Instead, special focus is required to ensure that preventive interventions have reach and 
effectiveness in populations that have worse risk factors and poorer health outcomes.  
This principle recognises the importance of working to achieve prevention from ‘both 
ends’ – driven or informed by a national agenda but with ownership and engagement by 
local communities.  
Local action is important for several reasons.  First, it helps build the community 
commitment for change that will be necessary for governments to make tough decisions. 
Second, it helps foster innovation and the development of local solutions to complex 
problems that require a multi-faceted approach, such as obesity.  Third, local 
engagement is critical in achieving change in hard-to-reach and/or disadvantaged 
communities that otherwise may not be receptive to top-down preventive interventions.  
In its report on preventing alcohol-related harm, the National Preventative Health 
Taskforce (NPHT) summed up the value of local action as follows:  
The contribution of community-level action is significant, and is integral to the 
effective implementation of federal, state and local government policies and 
programs (pg 4).  67
A life course approach includes acting early to prevent chronic diseases before their 
onset.  It includes opportunistic actions, as people age and develop risk factors, to 
reduce the impact of chronic diseases in high-risk populations.  It also recognises the 
intergenerational risks for the development of chronic diseases.  
As risk factors accumulate over a lifetime, interventions early in life can reduce the 
incidence of some risk factors and the subsequent development of chronic diseases. 
Initiatives to discourage children from ever smoking are an obvious and well-known 
example.   
Tackling health 
inequity
√ Work to improve and redress inequities 
in outcomes
National agenda 
with local action
√ Build commitment and innovation with 
local action
A life course 
approach
√ Intervene early and exploit prevention 
opportunities at all ages and across 
generations
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At early ages, other important initiatives are those that seek to tackle social 
disadvantage and create healthy environments for children’s physical, mental and 
emotional development.  This includes programs that foster resilience in adolescents ,  68 69
to help them build a strong adaptive response to adversity and to act as a ‘vaccine’ to 
prevent mental illness in young people and the uptake of risky behaviours such as drug 
use or binge drinking.  
The adoption of a life course approach recognises the importance of distal factors 
including social and economic determinants of health.  Hence, a life course approach also 
involves taking preventive action across all settings of life – such as schools, workplaces 
and community events – rather than taking a narrow focus that disease prevention only 
happens in health care settings.  
There is also an accumulation of chronic disease risk factors as people age.  The 
identification and management of high-risk groups – people with multiple risk factors 
and/or in the early stages of chronic diseases – requires secondary prevention that is 
usually delivered by primary health care and other health professionals.  There is also an 
increasing focus on secondary prevention in other settings through, for example, diabetes 
assessment programs in the workplace.   
A life course approach also recognises that chronic diseases do not only impact across the 
life cycle of individuals, but that the risks of chronic diseases can be ‘transmitted’ across 
successive generations.  This intergenerational aspect of the development of chronic 
diseases includes increased risk for chronic diseases due to epigenetic factors and social 
determinants that may affect the health and life chances of successive generations of 
families.  For example, intergenerational factors that increase the risk of obesity include 
maternal gestational diabetes, maternal birth weight and parental obesity.   70
In summary, a life course approach is based on early and opportunistic approaches to 
prevention at all ages and in all settings to protect the health of individuals, families and 
subsequent generations. 
As stated most succinctly by the NPHT, ‘prevention is everyone’s business’.  
This principle eschews the idea that unless governments take action, no significant gains 
will be made in preventing chronic diseases.  The priorities adopted by governments 
change over time, meaning that prevention will not always be ‘top of the agenda’ for 
governments.  While governments undoubtedly have an essential role in tax and 
regulatory policies, many other preventive interventions can involve leadership and/or 
participation by other agencies.   
Shared 
responsibility
√ Encourage complementary actions by all 
groups 
Responsible 
partnerships
√ Avoid ceding policy influence to vested 
interests
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Corporations (including food, alcohol and tobacco manufacturers) have obligations to 
their stakeholders to increase consumption of their products, but such consumption is 
incompatible with the public health objective of reducing exposure to risk factors for 
chronic diseases.  Although governments may seek technical input from these 
corporations, industry should not participate in processes that directly advise or guide 
government policy.  Such involvement constitutes ‘regulatory capture’ and creates a 
strong risk of public health objectives being compromised by commercial interests.   
Recent experience with food labelling provides an example of public health goals being 
subverted through the involvement of industry.  Public health advocates have not been 
able to achieve ‘traffic light’ labelling on food despite it being initially recommended in 
2009 by the NPHT and in 2011 by a Council of Australian Governments (COAG) 
commissioned review of food labelling law and policy.   Instead, the Health Star rating 71
system has been introduced on a voluntary basis only, with almost no promotion by 
government or industry to communicate how the scheme works and its benefits to 
consumers.   
Related to this, in 2009 the Australian Government established the Food and Health 
Dialogue (which includes public health, government and food industry representatives) to 
raise the nutritional profile of foods through reformulation, consumer education and 
portion standardisation.  A recent assessment of the Food and Health Dialogue found 
that: 
Few targets have been set, little objective evidence about progress has been 
provided, and there is a low likelihood that any real health gains have been 
achieved ... In the context of an industry in which profitability is substantially 
aided by the addition of salt, sugar and fat to foods, it is perhaps unsurprising 
that a voluntary model based on a public-private partnership faces these 
challenges ... In particular, it will be necessary to develop mechanisms that 
control for the significant conflicts of interest that exist for influential industry 
umbrella organisations like the Australian Food and Grocery Council.  While it is 
reasonable for such bodies to argue for a system that maximises profits, the 
Dialogue was established to reduce health problems, and this is not currently 
being achieved.  72
2.2 Strategic priority one: driving healthy behaviours and healthy 
environments 
The first strategic priority is effectively the ‘what to do’ element of this Blueprint.   
There are many hundreds of interventions that could be implemented to prevent chronic 
diseases.  Decisions about which interventions to implement will vary across time, 
settings and the perspective of stakeholders.  For example, the NHPT focussed on 
interventions related to tobacco, alcohol and obesity and identified interventions for 
action by governments, reflecting its remit and role.  Non-government organisations, 
community groups and health professionals will legitimately have different priorities as 
they have alternative levers available to them to influence the risk factors and 
determinants of chronic diseases. 
Accordingly, this Blueprint does not present a definitive list of priority actions.  Such a 
list runs the risk of becoming outdated (for example, as new evidence emerges on the 
effectiveness of particular interventions) or less relevant (for example, as political 
agendas change, necessitating a ‘reframing’ of prevention priorities).  
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Instead, this Blueprint provides a high-level strategic framework to guide decisions 
about how to select and prioritise prevention interventions to reduce the incidence 
and impact of chronic diseases.  In doing so, examples of important preventive 
interventions are highlighted, as are sources of information on how to assess and 
implement preventive interventions. 
In overview, the strategic framework for driving healthy behaviours and healthy 
environments involves: 
• Setting objectives for improved health (and other) outcomes that are underpinned 
by a systemic approach to preventing chronic diseases; and 
• Assessing potential interventions to achieve these objectives against a set of 
criteria that can help provide guidance about when to implement (or advocate for 
the implementation of) specific preventive interventions.  
These tasks are obviously closely related to the other strategic priorities included and 
discussed in subsequent sections of this Blueprint: 
• Creating accountability for action and monitoring progress; and 
• Generating community support for action on prevention.  
Setting objectives for improved health and other outcomes 
The one-page overview of this Blueprint identified seven ‘action areas’ under the 
strategic priority of driving healthy behaviours and healthy environments.   
 
These seven action areas are derived from Table 1.1, which identified the main risk 
factors and determinants (see column 2) contributing to many chronic diseases, as 
follows: 
• The health behaviours that are the most common risk factors for many chronic 
diseases have been directly mapped to the first four action areas. 
• Of the biomedical factors listed in Table 1.1, the risk factor of ‘depression’ has 
been mapped to a higher-level action area of ‘better mental health’.  The other 
three biomedical factors (hypertension, high cholesterol and excess weight) have 
been mapped to the high-level action area of ‘reducing biomedical risk factors’. 
This recognises that: 
o many of the actions to tackle excess weight are captured under the action 
areas of ‘healthier diets’ and ‘increasing physical activity’; and 
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1. Healthier diets 
2. Making smoking history 
3. Increase physical activity 
4. Decrease harmful use of alcohol 
5. Better mental health 
6. Decrease biomedical risk factors 
7. Tackle social determinants of health
o the evidence on management of biomedical risk factors stresses the 
importance of taking a comprehensive approach across multiple risk 
factors, instead of focussing on individual risk factors.  The most well-
known example of this approach relates to CVD.  The Australian guidelines 
emphasise the importance of measuring and managing absolute risk for 
CVD based on the combined effect of multiple risk factors.   73
• The social and environmental determinants listed in Table 1.1 have been 
mapped to the high-level action area of ‘tackling the social determinants of 
health’.  
The purpose of having these seven action areas as broad objectives is to ensure that 
there is a systemic approach to preventing chronic diseases.  The ‘systemic approach’ 
principle has previously been described as involving a focus on common risk factors and 
determinants, not individual diseases.  However, the systemic approach principle can be 
further understood to include: 
• taking action on multiple risk factors and determinants; 
• taking action using a range of policy levers and tools (this recognises the complex 
nature of the changes that are required to tackle risk factors and determinants); 
• taking and encouraging action by multiple participants (this recognises the 
complementary roles of different groups and their different capacities for action); 
and 
• taking and encouraging action in multiple settings (this recognises that there are 
many opportunities for tackling the risk factors and determinants including health 
care settings, workplaces, schools and community groups).  
Box 2.1 provides two examples of the value of a systemic approach to preventing chronic 
diseases.  Both examples illustrate the value of using a comprehensive array of 
complementary and reinforcing levers (such as fiscal policy, regulation, education, 
product safety changes) with different participants (such as governments, health 
professionals, industry, local organisations) responsible for, and contributing to, a 
coordinated web of action. 
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Box 2.1: Systemic approaches to preventing chronic diseases 
The value of a systemic approach is well-illustrated by Australian action on tobacco control over 
many decades, as shown in the diagram produced by the ANPHA.  Tobacco control has involved 
multiple policy levers and tools – regulation, taxation and pricing, advertising and educational 
campaigns.  
  
Source: ANPHA 2013, State of preventive health 2013, Canberra: ANPHA 
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Box 2.1: Systemic approaches to preventing chronic diseases (cont’d) 
Another good example of the value of multi-faceted action is shown in the NOURISHING framework 
developed by the World Cancer Research Fund International to describe actions that can be taken 
to promote healthy diets and reduce obesity.  The NOURISHING framework comprises: 74
➢ Nutrition label standards and regulations on the use of claims and implied 
claims on foods; 
➢ Offer healthy foods and set standards in public institutions and other specific 
settings; 
➢ Use economic tools to address food affordability and purchase incentives; 
➢ Restrict food advertising and other forms of commercial promotion; 
➢ Improve the nutritional quality of the whole food supply; 
➢ Set incentives and rules to create a healthy retail and food service 
environment; 
➢ Harness the food supply chain and actions across sectors to ensure coherence 
with health; 
➢ Inform people about food and nutrition through public awareness; 
➢ Nutrition advice and counselling in health-care settings; and 
➢ Give nutrition education and skills. 
Once, again, the NOURISHING framework does not rely on single interventions, but involves many 
interventions targetted at different aspects of the issue, including food supply, individuals and 
behaviour change, and the environment and context in which food is available.  
Assessing preventive interventions to determine implementation 
priorities 
Seven assessment criteria have been identified that could assist in making priority-setting 
decisions about the implementation of specific preventive interventions.  These are: 
1. What is the evidence on the effectiveness of the intervention? 
2. Are there successful working models for the implementation of the intervention? 
3. Is the intervention cost-effective? 
4. Is there political support for action on the intervention?  
5. Is there community support for action on the intervention? 
6. What is the magnitude of the health burden that the intervention is targetting? 
7. What will be the impact of the intervention on reducing health inequities related 
to chronic diseases? 
Many of these assessment criteria are closely related.  Each is briefly explained on the 
following page. 
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Evidence of effectiveness  
In making decisions about which preventive interventions to implement, an obviously 
important criterion is their comparative effectiveness.  Effectiveness has to be assessed 
against a specified outcome and is not an innate property of the preventive intervention. 
A commonly used approach in assessing effectiveness is the PICO approach, namely: 
• define the Population in which the intervention is being tested; 
• define the specific Intervention; 
• identify the Comparator against which the intervention is being assessed; and 
• define the Outcomes against which improvement should be measured.  
Using tax on sugar-sweetened beverages (SSBs) as one example, studies reviewing its 
effectiveness would specify the population (for example, children, low-income adults) for 
which measurement of outcomes (for example, reductions in consumption of SSBs, weight 
loss) and the comparator against which the intervention is being tested (for example, no 
tax, different levels of tax).   
Table 2.1 includes some of the many sources of evidence for the effectiveness (and 
the cost-effectiveness) of preventive interventions.  The sources listed provide 
information through systematic reviews, public health and clinical guidelines, knowledge 
databases and implementation tools for policy-makers, health practitioners and other 
groups seeking to implement interventions to prevent chronic diseases.  
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Table 2.1: Sources of evidence on preventive interventions 
The approaches to assessing the effectiveness of public health interventions  may differ 75
from clinical interventions, recognising that many public policy interventions involve real-
world changes that are not able to be tested using randomised controlled trials (such as 
the introduction of mandatory seatbelts). 
Source Description Link 
Cochrane Public 
Health Group 
Reviews of the effects of population-level 
public health interventions directed at the 
social determinants of health
http://ph.cochrane.org/home 
Sax Institute The Evidence Check Library comprises rapid 
literature reviews that assemble existing 
research and evidence to answer specific 
policy questions 
www.saxinstitute.org.au 
Health Evidence Database of over 4,000 quality-rated 
systematic reviews evaluating the 
effectiveness of public health interventions 
www.healthevidence.org 
Effective Public 
Health Practice 
Project
Undertakes systematic reviews related to 
the effectiveness of public health programs 
and interventions 
www.ephpp.ca 
Public Health 
Agency of 
Canada
The Canadian Best Practices Portal includes 
best practice information for chronic 
diseases, interventions, public health 
topics, as well as resources to implement 
health promotion and disease prevention 
interventions 
http://cbpp-pcpe.phac-
aspc.gc.ca/ 
NICE (National 
Institute for 
Health and Care 
Excellence) (UK)
Includes evidence-based guidance on 
quality standards, technology appraisals, 
clinical, public health and social care 
guidelines 
www.nice.org.uk 
Centre for 
Reviews and 
Dissemination 
(University of 
York, UK)
Forms part of the UK National Institute for 
Health Research, undertakes systematic 
reviews on health and public health issues, 
provides access to several research 
databases, maintains PROSPERO (the 
international prospective register of 
systematic reviews)
http://www.york.ac.uk/inst/
crd/ 
Evidence for 
Policy and 
Practice 
Information and 
Coordinating 
Centre  
Includes an evidence library of systematic 
reviews of research evidence across many 
fields including public health 
http://eppi.ioe.ac.uk/cms 
Evidence-
Informed Policy 
Network, WHO
Includes policy briefs, systematic reviews, 
rapid response and policy dialogue reports 
aimed at low and middle income countries
http://global.evipnet.org/ 
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Successful working models 
This criterion is clearly related to effectiveness, but has been listed separately due to the 
value of being able to point to examples of successfully implemented specific 
interventions.  For example, Australia is now being used as the model for other countries 
interested in implementing plain packaging of tobacco products; the experience of 
Mexico in implementing taxes on SSBs is being carefully studied to assess the evidence of 
its impact and applicability to other countries; and the United Kingdom (UK) is one of the 
comparator nations for groups interested in the implementation of salt reduction targets.   
Having access to working models in Australia or other countries adds real value that 
moves beyond the ‘does it work’ question to ‘what was needed to make it work’ and 
‘what were the barriers that had to be overcome’.  For example, an analysis of the UK 
salt reduction program yielded a ‘how-to’ guide of the key components that were 
essential in the successful implementation of this program (see Box 2.2).  These working 
models also provide access to policy, scientific, clinical, community and political experts 
that can be called upon to communicate the benefits of the proposed intervention to 
local decision-makers.  
Box 2.2: Implementing a successful salt reduction program in the UK 
A recent study identified the key components that were essential to the development and 
implementation of the UK’s salt reduction program .  The key components for success comprised: 76
“(1) setting up an action group with strong leadership and scientific credibility;  
(2) determining salt intake by measuring 24-h urinary sodium, identifying the sources of salt by 
dietary record;  
(3) setting a target for population salt intake and developing a salt reduction strategy;  
(4) setting progressively lower salt targets for different categories of food, with a clear time 
frame for the industry to achieve;  
(5) working with the industry to reformulate food with less salt;  
(6) engaging and recruiting of ministerial support and potential threat of regulation by the 
Department of Health;  
(7) clear nutritional labelling;  
(8) consumer awareness campaign; and  
(9) monitoring progress by (a) frequent surveys and media publicity of salt content in food, 
including naming and shaming, (b) repeated 24-h urinary sodium at 3–5 year intervals.” 
Evidence of cost-effectiveness 
The Australian Government has a long history of using cost-effectiveness analysis in 
determining which pharmaceuticals and medical procedures will be publicly subsidised 
through the PBS and MBS respectively.  While there is no similar assessment mechanism 
available for population-health preventive interventions, there are clear expectations by 
governments and other funders that such interventions should be cost-effective. 
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Section 1.4 indicated that there are many available studies (including the ACE-Prevention 
study) that have assessed the cost-effectiveness of preventive interventions to reduce 
the incidence and impact of chronic diseases.  Table 2.1 presented a range of sources 
that can be searched to determine whether there is evidence on the cost-effectiveness of 
particular preventive interventions.   
There is robust evidence on the effectiveness of many preventive interventions, with new 
evidence accumulating rapidly.  To cite one example, Table 2.2 provides evidence from a 
February 2015 study on the cost-effectiveness of various interventions to prevent 
childhood obesity.  In addition to summarising data on the cost-effectiveness of various 
interventions in different settings and for different target populations, the authors of this 
study also highlighted the emerging view that: 
These and other reviews generally suggest that, rather than single-component 
interventions, the most sustainable and beneficial effect on obesity prevention, 
involves multiple strategies that focus on meals, classroom activities, sports, and 
play activities, and involve home, school or kindergarten, and community 
participants.  77
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Table 2.2: Cost-effectiveness of childhood obesity prevention interventions 
Intervention Setting Target population Measure of health gain
Dominant interventions (positive financial benefits and health gains)
Reduction of 
advertising of junk 
food
Media Children 0-14 years Dominant (health gains and 
financial gains)
Education 
programme to 
reduce sugar 
sweetened drink 
consumption
School Primary school 
children 7-11 years
Dominant
Multifaceted 
targeted programme
School Overweight or obese 
primary school 
children 7-10 years
Dominant
Multifaceted 
programme including 
nutrition and 
physical activity
School Primary school 
children 6 years
Dominant
Education 
programme to 
reduce television 
viewing
School Primary school 
children 8-10 years
Dominant
Family-targeted 
programme
Clinical Obese children 10-11 
years
Dominant
Likely to be cost-effective (financial costs are worthwhile for the health gains)
Medical College of 
Georgia FitKid 
project
School (after 
hours)
3rd grade students US$317 per 0.76% reduction in 
body fat
Be Active Eat Well 
multifaceted 
community based 
programme
School Primary school 
children 5-12 years
Net cost per DALY saved AU
$29,798
APPLE multifaceted 
school-based 
programme
School Primary school 
children 5-12 years
NZ$664-1708 per kg of weight 
gain prevented
Multifaceted 
programme 
excluding nutrition 
and physical activity
School Primary school 
children 6 years
AU$21,300 per DALY saved
Cuenca Study school-
based physical 
activity programme
School Primary school 
children 9-10 years
€500 saved per 1% decrease in 
triceps skinfold thickness
Coordinated 
Approach to Child 
Health (CATCH)
School Children 8-11 years US$900 per QALY saved
Planet Health School Children 11-14 years US$4,035 per QALY saved
Family-based group 
treatment
Clinical Obese children 7-9 
years
€53 per 1% decrease in weight for 
height
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Notes: These estimates regard effectiveness in terms of obesity-reduction or change in body-mass index, but 
not other potential health benefits.  DALY = disability-adjusted life year. GP= general practitioner. RCT = 
randomised controlled trial. QALY = quality-adjusted life year.   
Source: Lobstein et al. 2015, ‘Child and adolescent obesity: part of a bigger picture’, The Lancet, 18 
February (online).  
Political support for action 
This criterion recognises the importance of being able to frame and put forward proposals 
in a way that resonates with each government’s agenda and policy priorities.  The well-
known example in public health circles is of the late Dr Nigel Gray waiting many years for 
the window of opportunity (a receptive Victorian health minister) to achieve the 
implementation of VicHealth.   
Selecting and advancing preventive interventions will similarly have to be couched in 
terms that recognise the public policy concerns and issues of the government of the day, 
both federally and at the state or territory level.   
Laparoscopic-
adjustable gastric 
banding
Clinical Severely obese 
adolescents 14-19 
years
AU$4,400 per DALY saved
Family-based GP-
mediated 
programme
Clinical Overweight or 
moderately obese 
children 10-11 years
AU$4,700 per DALY saved
RCT-evaluated 
lifestyle 
interventions to 
treat overweight and 
obesity
Clinical Obese children 10-11 
years
£13,589 per life-year gained
Family-based group 
treatment
Clinical Children 8-12 years Group treatment gave 14% 
reduction in overweight 
prevalence per $1000 spent
Unlikely to be cost-effective
Active after-school 
communities 
programme
School (after 
hours)
Primary school 
children 5-11 years
AU$82,000 per DALY saved
TravelSMART schools Neighbourhoo
d
Primary school 
children 10-11 years
AU$117,000 per DALY saved
Walking school bus Neighbourhoo
d
Primary school 
children 5-7 years
AU$760,000 per DALY saved
Intervention Setting Target population Measure of health gain
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Community support for action 
Political support for change is more likely if it can be demonstrated that there is public 
support for an intervention.  Measuring community support may involve identifying the 
net gain or loss of a specific intervention for different groups in the population.  For 
example, the costs and benefits of plain packaging of tobacco products may vary across: 
• tobacco manufacturers; 
• retailers; 
• the advertising industry;  
• current smokers; and 
• non-smokers. 
Building community support may often involve analysing and communicating the real 
costs and benefits of preventive interventions to rebut unsubstantiated claims (for 
example, about the potential impact of some interventions on employment or costs to 
industry).  
Community support is an important criterion in effecting preventive action and is 
discussed in more detail in Section 2.4. 
Magnitude and type of health (burden of disease) impact 
Chronic diseases can have varying health impacts that include premature mortality and 
impaired functioning, disability or quality of life.  For some chronic diseases such as CVD 
and many cancers, most of the burden of disease is due to early deaths.  For many 
chronic diseases such as mental health conditions, diabetes and chronic respiratory 
conditions, reduced quality of life is responsible for most of the burden of disease.  Table 
2.2 shows that health gains associated with preventive interventions can also be assessed 
using intermediate measures such as weight loss (or any favourable trends in the SNAP 
health behaviours).  
Impact on overcoming health inequities 
An important issue in assessing preventive interventions is understanding whether they 
will improve health outcomes equally across the whole population or whether they will 
be less effective in tackling risk factors in more disadvantaged populations.  Policy levers 
may vary in the extent to which they achieve behaviour change or reduce environmental 
risk factors for certain populations.  For example, tax increases or portraying smoking as 
‘not cool’ may be more successful in reducing smoking rates in some population groups 
than offering QUIT (smoking cessation) programs.  
This criterion is obviously closely related to how the initial policy objective is defined, as 
well as the accountability measures that will be used to measure progress.  Having the 
capacity to measure progress or improvement for key population groups (such as 
Indigenous Australians, low income groups, young people, migrant communities) is an 
important element in weighing up which preventive interventions should be 
implemented.  
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2.3 Strategic priority two: creating accountability for action and 
monitoring progress 
Having identified an approach through which preventive interventions can be assessed 
and prioritised for implementation, the next strategic priority is about creating systems 
of accountability to ensure that preventive interventions are successfully 
implemented with monitoring and public reporting as to their progress. 
There are several factors driving the decision to place substantial emphasis on 
accountability in this action Blueprint, including: 
• There has been a long history of governments agreeing to high-level ‘strategies’ 
related to preventing chronic diseases and/or risk factors for chronic diseases. 
Some of these strategies have been ‘aspirational’ with no translation into 
specified actions, timelines or budgets to ensure delivery.  This was the case with 
the 2005 National Chronic Disease Strategy and there is a risk that this may occur 
with future strategies (for example, the National Diabetes Strategy that is under 
development).  
• The disbanding of the ANPHA and the COAG Reform Council, together with the 
cessation of the National Partnership Agreement (NPA) on Preventive Health, has 
resulted in a lack of clarity as to where leadership and accountability for action 
on preventive health resides. 
• Balanced against this, the Australian Government is a signatory to the WHO Global 
action plan for the prevention and control of non-communicable diseases 
2013-2020, providing a new opportunity to reinvigorate action and reporting on 
preventing chronic diseases.  
Within this context, three different, but complementary, approaches to improving 
accountability for driving action on preventing chronic diseases have been identified and 
are outlined in the following pages. In addition to these three action areas, the key 
message is that rigorous (and preferably independent) accountability mechanisms need to 
be built into any future commitments on preventing chronic diseases.  
 
Australian implementation of WHO 25 x 25 targets 
In 2013, the World Health Assembly agreed to the WHO Global action plan for the 
prevention and control of non-communicable diseases 2013-2020.   The overall objective 78
of the WHO Global action plan is to achieve a 25 per cent reduction in premature 
mortality from chronic diseases by 2025 – known as the 25 x 25 target.   To achieve this 79
objective, the WHO Global action plan includes voluntary global targets related to risk 
factors and national system response (see Figure 2.1). 
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1. Australian implementation of WHO 25 x 25 targets 
2. Independent progress report cards 
3. Nationally focussed accountability agency
Figure 2.1: WHO has set global targets to achieve a 25 per cent reduction in 
premature deaths from chronic diseases 
  
Source: WHO 2014, Global status report on non-communicable diseases 2014, Geneva: 
WHO. 
The WHO has encouraged governments to set national chronic disease targets for 2025, 
against a 2010 baseline measurement, with progress reporting in 2015 and 2020.  As the 
Australian Government is a signatory to the WHO Global action plan, it is expected to set 
targets that are relevant to Australia (which may vary from the global targets presented 
in Figure 2.1) and report progress on an ongoing basis.  Although the WHO plan involves 
national governments, state and territory governments in Australia are integral to 
population-based prevention and have an important role in contributing to achievement 
of the targets.  
The Australian Health Policy Collaboration will work with partner organisations to 
auspice the development and implementation of an Australian set of indicators and 
targets that are consistent with the Global action plan’s objective of a 25 per cent 
reduction in premature mortality from chronic diseases by 2025.  
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This proposal for independent auspicing of an Australian chronic disease prevention 
indicator framework is based on the following assessment: 
• In Chronic Diseases in Australia: the case for changing course, the Australian 
Health Policy Collaboration reviewed chronic disease prevention targets previously 
set by Australian governments to determine any overlap with the WHO targets.  80
(Appendix 1 provides a summary table from this earlier report). This review 
identified that: 
o Australian governments have focussed on a narrow set of areas to measure 
the prevention of chronic disease.  For example, relative to the WHO 
Global action plan, measurable targets have not yet been established by 
Australia to tackle harmful alcohol use or limit salt intake. 
o The previous Australian targets related to obesity, smoking, physical 
activity and consumption of fruit and vegetables had the benefit of being 
challenging ‘stretch’ targets, the achievement of which would result in 
major improvements in health outcomes.  
• With the cessation of the NPA on Preventive Health, there is currently no specific 
avenue through which the Commonwealth and state and territory governments 
can jointly agree on actions, including targets and indicators, to prevent chronic 
disease.  
• Even if there was an existing intergovernmental agreement, there is benefit in 
having a more inclusive and open process for setting targets to prevent chronic 
disease.   
While the scope and approach to developing an Australian set of indicators and targets to 
prevent chronic diseases will evolve, the following guidelines constitute a starting point 
for this endeavour: 
1. The selection of domains for inclusion in a chronic disease prevention 
performance indicator framework should be comprehensive, rather than be 
limited to domains where there is currently good data and/or sufficiently well-
developed performance indicators.  The included domains should recognise the 
importance of both health behaviours and healthy environments as factors 
amenable to preventive interventions.  
2. This work should build upon existing Australian authoritative policy and data 
sources, which could include: 
o Targets and indicators included in previous and existing intergovernmental 
agreements and frameworks, such as the NPA on Preventive Health  and 81
the Performance and Accountability Framework.    82
o The NHPT’s advice. For example, the Taskforce proposed that 
implementation of its recommendations on alcohol harm reduction would 
result in a reduction from 20 per cent to 14 per cent in the proportion of 
Australians drinking at short-term risky/high-risk levels.   83
o State or territory government population health/chronic disease 
prevention plans. For example, the NSW state health plan includes 
measurable targets for reductions in smoking rates, overweight and obesity 
rates and risky drinking.    84
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3. The development of indicators should involve input from organisations with 
expertise in health indicator development, including the AIHW and NHPA.  The 
AIHW’s 2008 report on performance indicators provides an overview of the factors 
that should be considered in the selection, development, technical specification 
and reporting of indicators.    85
Independent progress report cards 
The WHO Global action plan provides a current opportunity and an authoritative 
organising framework through which targets can be set to reduce the incidence and 
impact of chronic diseases.  The process of setting and agreeing to achieve measurable 
targets represents a quantum leap forward from an approach that simply relies on 
agreeing to a new chronic disease strategy.  
Turning commitments and targets into action requires robust and independent 
accountability mechanisms.  This applies not only to accountability for progress on 
Australian targets under the WHO Global action plan, but progress on other preventive 
interventions to tackle chronic diseases.  Accountability is sometimes a ‘closed shop’ 
involving agreements between the Commonwealth and state/territory governments or 
between governments and industry through ‘dialogues’.  The risk is that this non-
transparent ‘mutual accountability’ can morph into ‘mutual appreciation’ , where the 86
parties set less challenging improvement targets or are not sufficiently rigorous in 
evaluating performance.  Good governance requires that accountability mechanisms are 
transparent and involve independent and impartial assessment.  
Accordingly, the Australian Health Policy Collaboration will work with partner 
organisations to support the development and publication of regular independent 
progress report cards on actions and outcomes in reducing the incidence and impact 
of chronic diseases.   
Our first report, Chronic diseases in Australia: the case for changing course, identified 
the absence of regular public reporting against chronic disease prevention targets.  It also 
noted that there are existing examples of independent groups issuing progress reports on 
different elements of the health system.  This includes: 
• The Australian Medical Association: The AMA has produced an annual report card 
on public hospitals since 2007.  It uses publicly available information produced by 
other organisations (such as the AIHW) to assess public hospital performance 
against government-determined standards and criteria, to identify areas for 
improvement and to make recommendations for future actions by governments.  
• The National Stroke Foundation: 2007 was also the year in which the National 
Stroke Foundation commenced its annual reporting via its National Stroke Audit 
Program through which it measures and publicly reports on adherence to the 
Clinical Guidelines for Stroke Management.  These reports include new audit data 
collected from participating hospitals, as well as analysis of existing data from 
other sources (such as the Australasian Rehabilitation Outcomes Centre).  The 
reports can be used by individual hospitals to benchmark their performance and 
identify areas for improvement, with recommendations also targetted at 
governments and other groups able to influence the quality of stroke care. 
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• Mental Health Australia: This organisation (previously known as the Mental Health 
Council of Australia) produces reports on a range of different aspects of the 
performance of the mental health system.  This has included analysis of issues 
affecting: mental health carers (2009, 2010, 2012); community mental health 
services (through the 2003 report, Out of hospital, Out of mind); and the status of 
mental health reforms in each state/territory (through the 2005 Not for Service 
report).  
The reports produced by these three organisations are examples of the value of 
independent reporting by agencies that are separate from government and not 
directly involved as providers or funders of health care services.  While many 
organisations issue advocacy reports, position statements and budget submissions, the 
key features of progress report cards that add value (as exemplified by the AMA, the 
National Stroke Foundation and Mental Health Australia) are that: 
• There is sustained analysis and public reporting on progress (or lack of progress) 
against a series of performance measures about improvements required in the 
health system.  The ongoing production of these reports (rather than being one-
off) gives them authority and promotes greater engagement by governments, 
other decision-makers and the community on the issues covered in these reports.  
• Performance measures are explicit and identified up-front (although they may 
evolve and be strengthened over time).  
• These reports focus less on demonstrating the existence and magnitude of the 
problem, but more on identifying potential solutions and tracking progress 
against these solutions.  They include specific proposals for improvement, rather 
than more generic advocacy submissions (such as calling for increased government 
funding).  
The combination of critical analysis and specific change proposals differs from reports 
produced by many government agencies, some of which are statutorily (or otherwise) 
prohibited from making policy recommendations.  
The Australian Health Policy Collaboration will work with other agencies interested in 
chronic diseases to develop an analysis framework that could be used as the basis of 
regular independent reporting.  In the initial years, this analysis framework could be 
directly based upon a set of Australian performance targets linked to the WHO Global 
action plan.  It could include: 
• reporting on the Australian ‘baseline’ data for the performance targets; 
• specification of the intermediate and final performance targets (including 
disaggregation of performance targets for specific population groups); and 
• identification of a range of preventive interventions that could support meeting 
the performance targets, together with a proposed implementation plan 
(including responsibilities and timeframes). 
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Nationally focussed accountability agency 
This action area is about embedding responsibility for national accountability for 
chronic disease prevention within a national agency.  An important distinction is that it 
is not necessarily about establishing a new agency; instead it is about ensuring that the 
function of nationally focussed accountability for chronic disease prevention is clearly 
vested with an agency, or alliance/coalition of agencies.  This agency (alliance of 
agencies) would assume leadership in reporting on progress and actions to prevent 
chronic diseases.   
The role of this nationally focussed acccountability agency would complement the work 
of many other organisations (including government, non-government and community 
groups) with an interest in chronic disease prevention.    
The rationale for including a nationally focussed accountability agency as a separate 
action area (over and above the development and release of independent progress report 
cards) is as follows: 
• An agency with a dedicated responsibility for prevention of chronic diseases helps 
provide a rallying point in raising public awareness and building community 
support for action on these issues.  In the mental health area, the establishment 
of beyondblue has created much more openness to discuss early intervention and 
management of mental illnesses.  This has been complemented by analytical and 
consultative work undertaken by the former Mental Health Council of Australia in 
documenting the need for reform of the mental health system.  
• A nationally focussed accountability agency can provide an organising framework 
which can help coordinate and integrate the outcomes of relevant research and 
projects undertaken by other organisations.  
This action area has been described as a ‘nationally focussed’ accountability agency to 
distinguish its purpose and orientation from its ownership/governance structures.  To 
ensure maximum engagement, it is preferable for such an agency to not be closely 
aligned to one level of government (that is, not a ‘Commonwealth’ agency).  There are 
some existing models of nationally focussed organisations that receive significant 
government financial support, but are able to maintain their independence.  However, 
there are inevitable trade-offs in balancing factors that might shape a nationally focussed 
accountability agency for prevention of chronic disease, including: the level of 
resourcing; the level of independence in scope, functions and reporting; and the level of 
authority and ability to influence key stakeholders.  
At this stage, this action area has been identified as a ‘placeholder’ concept.  It will 
be important to undertake further consultations to identify the level of support and 
interest in a nationally focussed accountability agency for prevention of chronic 
diseases.  This would involve understanding the value of different models in terms of 
scope, resourcing and governance.  
Some concluding comments on accountability 
The critical importance of robust accountability mechanisms in tackling chronic disease is 
highlighted in the following commentary on the WHO Global action plan: 
Promises are easy to make, but harder to deliver and even more difficult to 
monitor.  In the political declaration from the UN high-level meeting on non-
communicable diseases in September 2011, heads of state made many welcome 
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promises.  But how should the global community ensure that these commitments 
are adhered to?  How can all partners who support the political declaration be 
mobilised to ensure that tangible progress is being made on the commitments?  In 
one word, the answer lies in accountability.  87
A recently developed framework  highlights the value of a multi-stage approach to 88
accountability that involves the participation of governments, the private sector and 
‘civil society’ - the individuals and organisations that represent the views and interests of 
the community.  The accountability framework (initially developed to monitor healthy 
food environments, but with broad applicability to chronic diseases) proposes a four-
stage approach, comprising: 
1. TAKE the account: the first stage involves independent assessment and 
benchmarking of existing progress.  In the context of this Blueprint, this stage can 
be equated with the baseline measurement of progress that is at the core of the 
WHO Global action plan. 
2. SHARE the account: the next stage involves communicating progress and 
recognises the value of independent and credible third parties in disseminating 
information on progress.  An existing example of independent monitoring is found 
in the work of INFORMAS (the International Network for Food and Obesity/NCDs 
Research, Monitoring and Action Support).  This international network of public 
interest organisations and researchers has published a comprehensive rating of 
New Zealand government performance in regard to healthy food environments.  89
This Blueprint has also emphasised the value of independent progress report 
cards, with the Australian Health Policy Collaboration committing to develop an 
analytical framework that will support regular progress reporting on preventive 
action on chronic diseases.  
3. HOLD the account: this step is about ‘enforcement’ – the application of a range of 
incentives and disincentives to advance progress and ensure that commitments 
are turned into action.  It involves taking action for non-compliance and failure to 
meet agreed performance targets.  While enforcement is often viewed as a 
government responsibility, non-government organisations are increasingly holding 
both governments and the private sector to account.  Accountability includes an 
important role for the ‘public voice’ through community mobilisation and action 
to demand changes that will reduce the incidence and impact of chronic diseases 
(discussed later in Section 2.4). 
4. RESPOND to the account: the final step is about closing the loop through system-
wide improvements to policies and actions.   
The three action areas outlined in this Blueprint to strengthen accountability for taking 
action on preventing chronic diseases are underpinned by the principle of shared 
responsibility.  Accountability is not simply about national governments holding state and 
territory governments or the private sector to account for their performance.  It also 
involves bottom-up accountability with the community providing feedback to all levels of 
government and the private sector on progress in preventing chronic diseases. 
Accountability for action should be assigned, measured and reported as follows for 
different: 
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• levels of government: Commonwealth, state/territory and local governments; 
• settings: workplace, schools, community groups; 
• geographic areas: states/territories, local communities; and 
• population groups: adults/children; population groups based on factors such as 
Indigenous status, socio-economic status, ethnicity.  
Unless accountability is translated into measuring actions and progress at a local level, 
there is scope for significant pockets of ongoing poor progress with preventing chronic 
diseases.  This leads into the third strategic priority. 
2.4 Strategic priority three: generating community support and 
action on prevention 
The third strategic priority is driven by two core assumptions, namely: 
1. Action by government is necessary, but not sufficient, to prevent chronic diseases. 
While governments need to take responsibility for some actions such as regulation 
and tax, many of the levers to prevent chronic diseases sit outside 
governments – with community groups, individuals and families and the full range 
of non-government organisations.  The corollary of this is that prevention 
advocates cannot simply rely on calls for more government funding or regulation, 
but must also seek to identify the contributions that can be made outside 
governments.  
2. Community support is essential to achieving success in preventing chronic 
diseases.  Using nutrition and food safety as an example, it is clear that 
community support operates at several different levels: 
o Community support – the ‘will of the people’ - is often critical in 
encouraging governments to act.  Governments are now considering 
country-of-origin food labelling in response to community concerns arising 
out of health and safety issues with some imported food products. 
o Many preventive interventions (whether initiated by government or by 
other parties) will not be effective unless the community gets behind the 
intervention.  For example, a future evaluation of the Health Star food 
labelling system may find that this initiative has been ineffective. This will 
only change if there is widespread education and information about the 
scheme and consumers use their purchasing power to choose healthier 
products and reject those from manufacturers that fail to include the 
Health Star labelling.  
o Communities can initiate actions at a local (or a state/territory) level 
that are customised to local circumstances and priorities.  Examples 
include actions taken by individual schools to restrict the sale of unhealthy 
food products in school canteens and the phenomenon of farmers’ markets 
linked to public interest in the locavore movement.  
  | P a g e  xlvii
A u s t r a l i a n  H e a l t h  P o l i c y  C o l l a b o r a t i o n  2 0 1 5
Within this strategic priority, three potential action areas are outlined.  These are 
illustrative of some of the many streams of community support and action that could 
reduce the incidence and impact of chronic diseases.   
 
Community data and attitudes 
This action area covers two domains:  
• Ensuring there is robust data on risk factors, biomedical factors and social/
environmental determinants that is sufficiently disaggregated so that local 
communities can make informed decisions about their chronic disease priorities 
and where they want to take local action. 
• Capturing community attitudes on priorities for action on chronic diseases 
including specific preventive interventions in order to encourage action by 
governments, businesses and other relevant groups. 
One of the factors in mobilising community action is access to relevant information and 
data about the magnitude of chronic disease problems at a local level.  However, this is 
challenging as there are still significant data gaps at the national level and there is also 
little focus on making data accessible for easy use by local communities.  
At the national level, some of the data and/or analysis gaps and infrequent collection of 
key data include: 
• the last Australian Burden of Disease study was based on 2003 data, with the new 
study (based on 2010 data) being released in several stages in 2015 and 2016; 
• linked to this, reports on health expenditure associated with chronic diseases are 
quite dated; most AIHW publications on health expenditure for various chronic 
diseases relate to 2008/09; and  
• there was more than a 15-year gap between the administration of the 1995 
National Nutrition Survey and the 2011-12 Australian Health Survey (which 
included some data on nutrition, physical activity and biomedical measures).  
On the positive side, there is relatively frequent collection of national data on drug and 
alcohol use (including tobacco) through the National Drug Strategy Household Survey and 
other surveys conducted by groups such as Cancer Council Victoria.  
Among the most valuable data for use by local communities are the regular population 
health surveys undertaken by many state/territory health departments, with examples 
including: 
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1. Community data and attitudes 
2. Social media and smart technologies 
3. Chronic disease local action communities 
• The NSW Adult Population Health Survey and the Child Population Health Survey;  
• The Victorian Population Health Survey and the Victorian Health Monitor; 
• The WA Health and Wellbeing Surveillance system; 
• The SA Health Omnibus/Health Monitor Surveys; and 
• The Queensland Population Health Surveys.  
Turning to community attitudes, the conduct of surveys and opinion polls to gauge 
community interest and support for preventive interventions is often critical in driving 
changes by governments and businesses.  There has been a long history of including 
attitudinal questions in surveys on smoking behaviour and this also occurs in the National 
Drug Strategy household surveys.  Combining data on risk factor behaviours and attitudes 
can provide a stronger case for reform (for example, many surveys have shown that 
smokers favour restrictions which limit advertising or availability of tobacco products to 
protect children).   
Data on community attitudes to preventive interventions targetting nutrition, physical 
activity, biomedical factors and social determinants have not been routinely collected. 
There has not been the same level of sustained investment in credible, ongoing research 
on these issues by governments, non-government organisations or universities.  In part, 
this reflects the lack of a clear ‘home’ for such research (contrasting, for example, with 
the long-term ‘ownership’ by cancer councils of survey data on smoking attitudes and 
behaviours).  In part, it may also reflect the relative under-development of policy around 
desirable preventive interventions in these areas.  
Social media and smart technologies 
The significant role of social media and smart technologies in many people’s lives 
provides new avenues to manage risk factors and to encourage healthy behaviours. 
The juxtaposition of these technologies and the learnings from behavioural economics 
support options that combine personalised communication strategies with online support 
and monitoring (including both professional and peer group support) to help people 
prevent and manage risk factors and chronic diseases.  
The opportunities afforded by social media and smart technologies span the spectrum, as 
follows:  
• Encouraging healthy behaviours among asymptomatic (low-risk, healthy) people. 
• Early intervention for people with behavioural or biomedical risk factors. 
• Secondary prevention to reduce the progression of chronic diseases among high-
risk groups.  
The ‘quantified self’ phenomenon involves individuals self-tracking biological, physical, 
behavioural or environmental information through smartphones, apps and wearable 
technology.  Reports from the US indicate that: 60 per cent of adults are currently 
tracking their weight, diet or exercise routine (risk factors) and 33 per cent are 
monitoring factors such as blood sugar, blood pressure, headaches or sleep patterns 
(biomedical factors).  In addition, 27 per cent of US internet users track health data 
online; and 9 per cent have signed up for text message health alerts.   There are at least 90
40,000 smartphone health applications available,  and it is estimated that by 2016 there 91
will be 80 million sports, fitness and wellness wearable devices in use.    92
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While health-related self-tracking may have initially been limited to ‘gym junkies’ and 
high-income, healthier populations, there are now very high levels of smartphone/device 
ownership and social media use across Australia.  About half (46 per cent) of Australians 
surveyed are using social media at least daily , with high shares of users employing social 93
media to get information on news and current events, to undertake research and to find 
people with similar interests (all factors that might align with taking action to prevent 
risk factors and chronic diseases).  The use of smart technologies is also resulting in 
‘quantified communities’: one example is employment-based fitness challenges where 
teams of staff compete to monitor their physical activity over a fixed period of time.  
Moving beyond the use of these technologies in healthy individuals, there is also 
burgeoning use of online interventions or portable devices in supporting people with risk 
factors and/or chronic diseases.  Telehealth and ehealth options are particularly well-
developed in mental health.  The UK Psychology Online service provides cognitive 
behavioural therapy via instant messaging with a qualified therapist.   Australia has 94
many well-established online mental health early intervention and support services 
including MoodGym, ReachOut and e-Couch , often with a focus on adolescents and 95
young people (who experience a high prevalence of mental health problems).  GPS 
tracking devices have been used to balance independence and safety for older people in 
the early stages of dementia through the ability to set virtual boundaries (with alerts to 
family members).  Sensors and health apps can help patients with chronic conditions 
better manage their diseases, as well as providing downloadable data for review by 
health professionals.  For example, Asthmapolis track’s use of different types of asthma 
medication by a patient with an inhaler sensor .  The UK-based innovation foundation, 96
Nesta, has estimated that the adoption of ‘people-powered health’ innovations to 
manage patients with long-term health conditions could achieve savings of 20 per cent of 
health costs.  97
Targetted messaging, personalised coaching of individuals in the early stages of chronic 
diseases and promoting change through peer/community groups of like-minded 
individuals provide new prevention opportunities that support patient empowerment and 
have potentially very extensive reach.  This changes the paradigm about responsibility for 
prevention being focussed around individual interactions between patients and health 
professionals to a scenario where individuals access information and advice from many 
sources.  One of the obvious challenges in this environment is ensuring that there are 
high-quality sources of information to support evidence-based behavioural change and 
risk factor management.  Another implication is the need to evaluate the cost-
effectiveness of these new approaches to reducing risk factors and preventing chronic 
disease progression compared to more traditional ‘static’ educational campaigns (such as 
advertisements on nutrition and physical activity).   
This action area of social media and smart technologies is one where governments are 
not necessarily well-placed to take leadership, with most of the innovation occurring in 
the private and non-government sector.  However, some governments are crowdsourcing 
the policy problem for solutions to be developed by the private sector.  In the US, 
government agencies use www.challenge.gov to specify ‘challenges’ for which solutions 
are required, including in the health risk factors and chronic disease prevention/
management space. Recent examples include: 
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• VizRisk: a challenge to submit health risk data visualisations that inform personal 
and policy decisions. 
• 2014 million hearts hypertension control challenge: a challenge that identified 30 
hypertension ‘control champions’ who had developed successful approaches to 
management of hypertension.  
• Behavioural health patient empowerment challenge: a challenge seeking the best 
apps that empower patients to manage their behavioural health (for mental 
health and substance abuse issues).  
• Reducing high-risk drinking among college students: a challenge seeking 
technology-based products to decrease the acceptability of, and engagement in, 
high-risk drinking among university students.  
Chronic disease local action communities 
Action at the local level provides a vital complement to national or state and territory 
government action and allows involvement of a wide array of groups.  This can include: 
• groups ‘outside’ the health sector, including sporting clubs, church groups, 
school canteen groups, local councils, neighbourhood residents’ associations, local 
businesses and many other groups; and  
• health sector groups, including Primary Health Networks, local health networks 
and other health professionals.  
Many local councils have taken a longstanding interest in population health issues 
including links to broader planning, transport and urban design policies.  In Victoria, for 
example, local councils are required to develop municipal public health and wellbeing 
plans that have the objectives of preventing or minimising public health dangers and 
enabling people living in the municipality to achieve maximum health and wellbeing. 
Promoting ‘liveability’ and ‘healthy communities’ is also likely to be of interest to local 
businesses and employer groups.  
For health sector providers, much of the focus is on secondary and tertiary prevention for 
high-risk populations with risk factors or chronic diseases.  However, this is less the case 
for Medicare Locals and the new Primary Health Networks, which have legitimately had a 
stronger focus on needs assessment and population health planning.  
In terms of ‘activating’ or supporting local groups to take action on preventing 
chronic diseases, local councils and Primary Health Networks provide two structural 
mechanisms that could play an important role.  
Some concluding comments on community support and action 
The three action areas described above only skim the surface of the substantial, but 
underutilised, capacity for local action in preventing chronic diseases.  By definition, 
local actions cannot be ‘prescribed’ from a top-down perspective, although national or 
state and territory government support can encourage their uptake and the dissemination 
of successful local actions to other communities. 
The Australian Health Policy Collaboration is committed to actionable policy proposals 
that span the continuum from national to local/grassroots actions to prevent chronic 
diseases.  In terms of the overall strategic priority of generating community support for 
action on prevention, the Australian Health Policy Collaboration will work with partner 
organisations to: 
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• Identify existing gaps in community data and attitudes in order to inform 
investment priorities for research in these areas. 
• Map examples of best practice in the use of social media and smart technologies 
in preventing chronic diseases in order to build awareness and increased 
utilisation of the opportunities afforded by these mechanisms. 
• Identify ‘local success stories’ in actions to prevent chronic disease in order to 
encourage translation and uptake of local successes more broadly.  
2.5. Partnerships – sharing responsibility for action 
 
This Blueprint is based on the view that ‘prevention is everyone’s business’.   
As stated in one of the underpinning principles, there should be a national agenda on 
the shared priorities to prevent chronic diseases that is complemented by local 
action.  Prevention should include both top-down and bottom-up approaches involving all 
the partners listed above (which can be summarised as comprising governments, the 
private and non-government sectors and communities).  
As identified in the third strategic priority of generating community support and action 
on prevention, local engagement and action is essential to achieving sustainable 
changes in the prevention of risk factors, social determinants and chronic diseases. 
Local engagement will include actions taken by individuals and families, community 
groups, schools, sporting groups, local councils and local employers, such as: 
• Implementing preventive interventions in local settings – healthy public spaces 
and liveable communities that encourage physical activity and community 
connectedness; regulations and policies that protect population health such as 
random breath testing and lockout laws for premises selling alcohol; and 
education and support through schools, workplaces and community groups to 
encourage uptake and retention of healthy lifestyles.  
• Advocacy and holding governments and businesses to account for the delivery 
of interventions that foster reductions in all the risk factors for chronic diseases.   
Moving up from local action, organisations with a major role in society (such as 
employers and business associations, non-government organisations, the media and 
advertising industry, health services and private health insurers) have to use their 
varying skills and influence to effect systemic changes in preventing chronic diseases. 
Finally, governments must provide leadership and implement preventive actions in 
areas in which they are sovereign, including taxation, regulation and other structural 
policies.   
Shared responsibility for taking preventive action is also fundamental to harnessing the 
value of implementing preventive actions across multiple settings.  This includes health 
care settings (for the provision of preventive interventions to high-risk groups) and all the 
other settings in which individuals learn, work, play and live (for the delivery of 
population-based preventive interventions).  
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PARTNERS: Individuals and families, community groups, educational institutions, 
local governments, health services, private health insurers, employers and business 
associations, sporting associations, non-government organisations, the media and 
advertising industry, Commonwealth and state/territory governments
Finally, an important element of a partnership approach to prevention of chronic 
diseases is consistency of messaging.  A former health minister identified this as a 
critical feature in the success of tobacco control advocates in influencing government 
policy, stating that: 
So, not 10 different people all asking for 20 different things.  That [cohesiveness] 
happens much more rarely than you would imagine in politics.  I think the value 
of the cut-through of a message like that, and how easy it then is for 
governments to pick it up, shouldn’t be underestimated. (pg 120)  98
The Australian Health Policy Collaboration will use this Blueprint to work with a range 
of partners in promoting a short, consistent set of messages about preventing chronic 
diseases.  The key outcomes – healthy lives, healthy children, healthy communities and 
healthy economies –paint a clear picture of the benefits that can be achieved through 
successful implementation of interventions to reduce the incidence and impact of chronic 
diseases.  It will be important for all partners to identify specific examples (as illustrated 
previously in Section 1.2) of the real gains that can be achieved under these four key 
outcomes of healthy lives, healthy children, healthy communities and healthy economies.  
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3.Conclusion 
This Blueprint identifies strategic priorities for taking action to prevent chronic diseases. 
It has been developed with input from leading experts, and focusses on a group of 
diseases that AIHW has identified as the greatest problem facing Australia’s health 
system. 
The vision of this Blueprint is to reduce the impact and incidence of chronic diseases 
through preventive interventions.  A concerted and consistent effort is needed and action 
is required on several fronts and from many players. This paper argues that we have no 
choice: change must happen if Australia is to realise its social and economic goals of: 
• Healthy lives: improved health status for all populations. 
• Healthy children: a healthy future for our children. 
• Healthy communities: more liveable and socially connected communities. 
• Healthy economies: increased economic participation and productivity. 
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Appendix 1: Australian and WHO targets 
to prevent chronic diseases 
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Domain WHO Global Action 
Plan
National Partnership Agreement on Preventive 
Health
Performance 
and 
Accountability 
Framework
Alcohol 
use
Target: 10% 
reduction in harmful 
use of alcohol 
between 2010 and 
2025
Outcome: reduce the harmful and hazardous 
consumption of alcohol 
Indicator: no indicators specified
Not included in 
Framework
Physical 
inactivity
Target: 10% 
reduction in physical 
inactivity between 
2010 and 2025
Outcome: increase the proportion of children and 
adults meeting national guidelines for healthy eating 
and physical activity by 15 per cent within six years (by 
1 January 2015) 
Performance benchmark: increase in proportion of 
children participating in at least 60 minutes of 
moderate physical activity every day from baseline for 
each state by five per cent by 2013; by 15 per cent by 
2015 
Performance benchmark: increase in proportion of 
adults participating in at least 30 minutes of moderate 
physical activity on five or more days of the week of 5 
per cent from baseline for each state by 2013; 15 per 
cent from baseline by 2015
Not included in 
Framework
Salt Target: 30% 
reduction in salt/
sodium intake 
between 2010 and 
2025
Objective: work with the food supply and the food 
service sectors towards offering healthy choices and 
minimising choices high in fat, sugar or salt
Not included in 
Framework
Tobacco 
use
Target: 30% 
reduction in tobacco 
use between 2010 
and 2025
Outcome: reduce the proportion of Australian adults 
smoking daily to 10 per cent within ten years (by 1 
January 2019) 
Indicator: reduction in state baseline for proportion of 
adults smoking daily commensurate with a two 
percentage point reduction in smoking from 2007 
national baseline by 2011 and a 3.5 percentage point 
reduction from 2007 national baseline by 2013
Population 
health outcome 
measure: 
Prevalence of 
smoking 
Blood 
pressure
Target: 25% 
reduction in raised 
blood pressure 
between 2010 and 
2025
Not included in Agreement Not included in 
Framework
Diabetes
/obesity
Target: 0% increase 
in diabetes / obesity 
between 2010 and 
2025
Diabetes: not included in Agreement; Obesity – several 
benchmarks  
Outcome: increase the proportion of children and 
adults at healthy body weight by 3 percentage points 
within ten years (by 1 January 2019) 
Performance benchmark: increase in proportion of 
children/adults at unhealthy weight held at less than 
five per cent from baseline for each state by 2013; 
proportion of children/adults at healthy weight 
returned to baseline level by 2015 
Performance benchmark: increase in mean number of 
daily serves of fruits and vegetables consumed by 
children/adults by at least 0.2 for fruits and 0.5 for 
vegetables from baseline for each state by 2013; 0.6 
for fruits and 1.5 for vegetables from baseline by 2015
Population 
health outcome 
measure: 
Prevalence of 
diabetes 
Population 
health outcome 
measure: 
Prevalence of 
overweight and 
obese status
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Source: Willcox, S. 2014, Chronic diseases in Australia: the case for changing course, Australian Health Policy 
Collaboration Issues paper No. 2014-02. Melbourne: Australian Health Policy Collaboration. 
Mortality Target: 25% 
reduction in 
premature mortality 
from NCDs between 
2010 and 2025
Not included in Agreement Indicator: Age 
standardised 
mortality of 
potentially 
avoidable 
deaths 
Drug 
therapy 
and 
counselli
ng
Target: at least 50% 
of eligible people 
receive drug therapy 
and counselling to 
prevent heart 
attacks and strokes
Not included in Agreement Not included in 
Framework
Access to 
technolo
gies and 
medicine
s
Target: An 80% 
availability of the 
affordable basic 
technologies and 
essential medicines, 
including generics, 
required to treat 
major NCDs in both 
public and private 
facilities
Not included in Agreement Not included in 
Framework
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Acronyms 
ACE Assessing Cost-Effectiveness
AIHW Australian Institute of Health and Welfare
ANPHA Australian National Preventive Health Agency
COAG Council of Australian Governments
CKD Chronic Kidney Disease
CVD Cardiovascular Disease
DALY Disability Adjusted Life Year
GP General Practitioner
NCD Non-Communicable Disease
NHMRC National Health and Medical Research Council
NHPA National Health Performance Authority
NPA National Partnership Agreement
NPHT National Preventative Health Taskforce 
WHO World Health Organization 
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